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ANALYSIS OF THE BIOCHEMICAL AND CELLULAR ACTIVITIES OF SUBSTRATE BINDING BY
THE MOLECULAR CHAPERONE HSP110/SSE1

Veronica Margarita Garcia, B.S.
Advisory Professor: Kevin A. Morano, Ph.D.

Molecular chaperones ensure protein quality during protein synthesis, delivery, damage
repair, and degradation. The ubiquitous and highly conserved molecular chaperone 70-kDa heatshock proteins (Hsp70s) are essential in maintaining protein homeostasis by cycling through high and
low affinity binding of unfolded protein clients to facilitate folding. The Hsp110 class of chaperones
are divergent relatives of Hsp70 that are extremely effective in preventing protein aggregation but
lack the hallmark folding activity seen in Hsp70s. Hsp110s serve as Hsp70 nucleotide exchange factors
(NEF) that facilitate the Hsp70 folding cycle by inducing release of protein substrate from Hsp70, thus
recycling the chaperone for a sequential round of folding and allowing successfully folded substrates
to exit the folding cycle. In the model organism Saccharomyces cerevisiae, Hsp110 is represented by
the proteins Sse1 and Sse2, which possess an Hsp70-like substrate binding domain (SBD), making
them unique among other functionally similar, but structurally distinct, NEFs. Studies of Hsp110 and
Sse1 have demonstrated that this chaperone/NEF family can bind polypeptides and prevent proteins
from aggregating in vitro and that this ability is conferred by the SBD. However, attempts to study
Hsp110 protein binding in vivo have not been successful. To date, the impact of peptide binding by
Hsp110 is unknown. This study elucidates and defines substrate binding by the yeast Hsp110 and
addresses the contributions of this activity toward protein and cellular homeostasis as well as begins
inquiries into substrate binding by the Drosophila melanogaster Hsp110, Hsc70cb. As a major partner
of Hsp70, determining cellular Hsp110 activities is a prerequisite to a full understanding of chaperonemediated protein homeostasis. By studying chaperone functions and activities in yeast and animal
vi

models, we can understand human cellular protein quality control systems which can then be
pharmacologically targeted to combat protein conformational disorders, including Alzheimer’s,
Huntington’s, and Parkinson’s diseases.
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Chapter 1: Introduction

1

Stress and protein quality control

Most cellular functions are carried out by proteins which must fold into a proper threedimensional configuration, or native state. Nascent polypeptides possess all the biophysical
information required to achieve the native state, but the process of protein folding is complex and
often vulnerable to translation errors and environmental factors (1-4). As newly synthesized proteins
exit the ribosome, these unfolded polypeptides run the risk of misfolding or aggregating. Large
complex polypeptides cannot acquire their proper secondary or tertiary structure until the entire
necessary domain or domains required for proper folding have exited the ribosome (5, 6).
Exponentially growing yeast contain approximately 105 active ribosomes per cell (7, 8). In typical
mammalian cells approximately 106 to 107 ribosomes are translating RNA into protein (9). This much
ribosomal activity within one cell necessitates the aid of a network of molecular chaperones to
maintain a functional proteome. Molecular chaperones help other proteins achieve their native
conformations by stabilizing folding intermediates without becoming part of the final structure of
those proteins (5).
Under optimal conditions, molecular chaperones help in de novo protein folding, repairing
misfolded substrates, maturation and translocation of proteins, and promoting the degradation of
irreparable proteins (5, 10). Chaperones act as a cellular quality control system and protect newly
synthesized polypeptides by binding the exposed hydrophobic regions of unfolded proteins. They
preventing aggregation and allow proteins to fold in a protective environment thus preventing
premature degradation (11). In addition to promoting nascent polypeptide folding, chaperones repair
proteins that are damaged post-translation. For example, when cells are exposed to heat stress,
damaged proteins segregate into aggregates until chaperones rescue and refold them (12-14).
Producing proteins is energy and resource intensive therefore the protein quality control machinery
first attempts to repair proteins where energy has already been spent (15). While chaperones
2

typically function as protein folding machines, they play an important role in determining when a
protein is fatally damaged and repair is not a possibility. Chaperones have to recognize misfolded
proteins and facilitate their refolding to avoid protein aggregates. When this fails or the misfolding is
irreversible, chaperones have to recognize this terminal state and target the protein for degradation
(16). Irreparably misfolded proteins are delivered for proteolysis and eradicated by the ubiquitin
proteasome system which tags substrates with ubiquitin and delivers them to the 26S proteasome
(17). This process is part of protein quality control and depends on molecular chaperones cooperating
with specific ubiquitin protein ligases (18-20).
Proteostasis can be defined as the balance of biosynthetic and turnover activities of the
proteome (21). Proteomic stress such as fluxes in pH, temperature, or reactive chemical compounds
can wreak havoc on proteostasis and may cause proteins to misfold and aggregate. These stresses
induce the expression of chaperones through activation of the unfolded protein response (UPR) or the
heat shock response (HSR) in the ER or the cytosol respectively (22-24). The heat shock response is a
transcriptional activation that induces protective genes encoding molecular chaperones, or the Heat
shock Protein (HSPs) (25) . Chaperones are classified according to their molecular weight, i.e. Hsp40,
Hsp70, Hsp90, and Hsp110 and into classes by functional similarity. Stress-induced stimulation of the
HSR is important to combat the serious risk of unfolded protein accumulation that can result in the
formation of aggregates that can be detrimental to cell health (26). Furthermore, aggregate
associated sequestration of chaperones can lead to a deficit of chaperone-mediated activities. For
instance, cellular functions such as clathrin-mediated endoctytosis are dependent on a consistent
pool of chaperones (27). The HSR and HSPs are required for cells to recover from, adapt to, and
resume growth under stress conditions that may perturb cellular proteostasis (28).

3

The Hsp70 machine

Heat shock protein 70 (Hsp70) chaperones are highly conserved and ubiquitous, and they
possess an astounding functional diversity considering the high level of conservation among homologs
and across species. These chaperones are central players in proteome maintenance as they are
involved in folding of nascent polypeptides, delivering proteins to different organelles, refolding
damaged proteins, and targeting proteins for degradation that are terminally misfolded.
Hsp70 recognizes its substrates by the exposed hydrophobic regions of unfolded polypeptides
and binds a stretch of approximately seven amino acids rich in aliphatic residues (29-30). Its function
is fundamentally an activity executed by nucleotide-dependent cycles of substrate binding and
release. Hsp70 requires the J-domain (also known as J-proteins and Hsp40) and nucleotide exchange
factor (NEF) to drive the ATP cycle and the promiscuous client recognition.
The canonical Hsp70 protein is divided into two major domains. The amino-terminal ATPase is
known as the nucleotide binding domain (NBD) (44 kDa) whereas the carboxy-terminus includes a
substrate binding domain (SBD) (27 kDa) that can be subdivided into a β-domain and an α-domain
(Figure 1-1) (31, 32). Hsp70 possess a nucleotide-driven interdomain communication that causes
conformational changes based on its ATP or ADP binding state (33-35). The SBD binds substrates
through a binding cleft in the SBD β. When Hsp70 is ADP-bound, substrate binding switches to a high
affinity state due to a domain reorientation which is driven by ATP hydrolysis in the NBD. The
conformational change in Hsp70 induces a “clamping down” of the SBD α on the SBD β to confer highaffinity substrate binding (34-37). Hsp70 must cycle between high- and low-binding affinity states in
order to allow protein clients to fold.

4

Figure 1-1 Comparative representation of Hsp70 and Hsp110 proteins. Both proteins are structurally
divided into two major domains which are the nucleotide binding domain (NBD) at the N-terminus
and the substrate binding domain (SBD) at the C-terminus. Hsp110 possess an extender spacer region
between the beta sandwich (SBD β) and the alpha helical bundle (SBD α) at the C-terminus.
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The different nucleotide-dependent binding states are regulated by cochaperones. At basal
levels, Hsp70 has a very low rate of ATPase activity and nucleotide exchange. The basal ATP hydrolysis
rate of the bacterial Hsp70 is 0.040 ± 0.007 min-1 and the nucleotide dissociation rates of various yeast
and human Hsp70s ranges from 0.2-0.5 s-1 (33, 38-40). This characteristic low level of ATPase and
nucleotide exchange activity is accelerated by the Hsp40 chaperones (also known as J-proteins) and
nucleotide exchange factors to accelerate both activities and promote functional cycling (Figure 1-2).
Hsp40 proteins induce the intrinsic ATPase of Hsp70 causing a conformational change that increases
the affinity of client binding (41-43). The NEFs promote a recycling of Hsp70 by triggering the release
and exchange of ADP for ATP (39, 44-46). They bind to the Hsp70 NBD inducing a conformational
change in that domain that triggers the release of the ADP nucleotide (47). When the nucleotide is
ejected from the NBD, Hsp70 returns to a low affinity binding state and the bound substrate is
released (40, 48). A new ATP molecule is bound by the NBD and a new Hsp70 folding cycle begins.
Hsp70 functional specificity can be ascribed to these cochaperones which are more adapted to
specific functions.

6

Figure 1-2. Cooperative folding by Hsp70, Hsp40, and Hsp110. The nucleotide dependent Hsp70
protein folding cycle proceeds with the help of the cochaperones Hsp40 and nucleotide exchange
factors (NEF) to produce a folded protein. The NEF depicted here is the Hsp110. The unfolded
polypeptide is depicted as a dotted line and as a solid line when fully folded.
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Hsp40 chaperones are classified based on the J-domain, a 70-amino acid domain containing a
conserved histidine-proline-aspartate (HPD) tripeptide sequence modeled in the bacterial DnaJ (42).
All Hsp40s have the J-domain in common, but they can have many other domain variations.
Additionally, Hsp40s are classified as type I, type II, or type III by the similarity of each chaperone to
DnaJ outside of the J-domain (49). The HPD allows J-proteins to interact with the Hsp70 NBD,
prompting its intrinsic ATPase activity (50, 51). Hsp40s induce the ATPase of Hsp70 to increase
substrate binding affinity but can also bind substrate clients themselves (52). Based on in vitro
characterization, a triprotein complex is formed where Hsp40 recognizes and binds unfolded proteins
and presents the substrate during the interaction with the Hsp70 NBD (53, 54). J-domain proteins
increase the effectiveness of the Hsp70 protein folding machine by binding chaperone substrates and
delivering them to Hsp70 (52, 55-56). In yeast, either of the two major cytosolic Hsp40s, Ydj1 or Sis1,
and their substrate binding function is required to maintain cell viability (57). These data are evidence
that Hsp40 activities include inducing ATP hydrolysis in Hsp70 and facilitating substrate recognition
and binding by Hsp70.
Although Hsp70 possesses a low rate of intrinsic nucleotide exchange activity in vitro, NEFs facilitate
nucleotide exchange and are clearly vital for Hsp70 function in vivo as absence of cytosolic NEF
function is lethal in yeast (33, 39, 45, 58). As previously mentioned, the NEFs allow for the quick
nucleotide cycling required of Hsp70. They make contact with the bi-lobular Hsp70 NBD and cause it
to collapse around the ADP molecule so the nucleotide-binding pocket cannot function (46, 59, 60).
Release of the hydrolyzed nucleotide leaves the NBD free to bind another ATP molecule and begin a
new Hsp70 folding cycle. NEFs can be classified into four unrelated groups: homologs of the protein
GrpE from Escherichia coli, the human Hsp70-binding protein 1 (HspBP1), the Bcl-2 associated
athanogene (BAG) proteins, or the Hsp110 proteins. Unlike the J-domain of Hsp40s, there is no
functional domain that is common to the NEFs. While all NEFs make contact with the Hsp70 NBD to
perform the nucleotide exchange activity, the varied structure of each NEF class dictates a different
8

mechanism of Hsp70 interaction (61, 62). For example, HspBP1 contains four α-helical repeats that
constitute an armadillo-like domain that makes contact with Hsp70 (63). Hsp110 proteins are
divergent members of the Hsp70 family of proteins. They interact with Hsp70 through their own NBD
and their C-terminus (59). Even though the NEFs vary in structure and domain composition, they all
interact with the same region of the Hsp70 NBD (64).

Hsp70•Hsp40•NEF complexes throughout the yeast cell

In the Saccharomyces cerevisiae cytosol, Hsp70 is represented by two families of proteins. The
Ssa family is encoded by SSA1-4 (Stress-Seventy subfamily A) which share functional homology and
are differentially transcriptionally regulated (65). The SSA1 and SSA2 isoforms are constitutively
expressed while SSA3 and SSA4 are stress inducible under the control of the Hsf1 transcription factor
(66). The Ssb family is encoded by SSB1-2 (Stress-Seventy subfamily B) which are functionally
interchangeable (66). Ssa chaperones can fulfill some Ssb functions, but Ssb cannot fulfill all Ssa
functions as deletion of all SSA isoforms is lethal (67). Ssb chaperones are regulated in a similar
fashion to ribosomal proteins and their transcription is reduced upon heat shock of yeast cells (68,
69). There are 13 cytosolic and nuclear Hsp40s in yeast that are involved in cytosolic general protein
folding, peroxisomal import, ribosome biogenesis, and vesicle trafficking (65). Of these, Caj1 and
Cwc23 are strictly localized in the nucleus (70). The yeast cytosol possesses three classes of cytosolic
NEFs, with human orthologs: the Hsp110-type proteins Sse1/Sse2 (Stress-Seventy subfamily E), the
HspBP1-type protein Fes1 (Factor Exchange for Ssa1p) and the BAG-1-type protein Snl1 (Suppressor of
Nup116-C Lethal) (71-75).
Protein folding in the cytosol and nucleus is executed by an overlapping chaperone network.
The Hsp40s, Ydj1 (Yeast DnaJ) and Sis1 (SIt4 Suppressor), help the cytosolic Hsp70 Ssa prevent protein
aggregation (52). Although both Ydj1 and Sis1 enhance the ability of Ssa to reactivate unfolded
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proteins, Ydj1 is more effective at inducing this Ssa behavior than Sis1. Furthermore, Ydj1 is essential
to help cells cope with heat stress and in its absence are non-viable (52, 76). Large aggregate
resolubilization by Hsp70 requires the concerted effort of the ATP-dependent Hsp100 family of
proteins (26). In yeast, these proteins are located in the cytosol and in the mitochondrion to provide
compartment-specific protection by interacting with the local Hsp70s (77). Hsp104, a member of the
Hsp100 family, is greatly induced upon thermal stress and functions to reactivate aggregated proteins
by translocating polypeptides through the ring formed by its hexameric complex (26). Hsp100
chaperones act cooperatively with the Hsp70 machine to dissaggregate and reactivate misfolded
proteins (1).
The high expression of Ssb during cell growth is consistent with its primary function of folding
nascent chains on translating ribosomes along with the ribosome associated complex (RAC). RAC is a
heterodimer complex that works exclusively at the ribosome and is composed of the Hsp40, Zuo1
(ZUOtin), and the atypical Hsp70, Ssz1 (Stress-Seventy subfamily Z) (78). Ribosomal interactions of Ssb
through RAC are conferred exclusively via Zuo1 which induces the ATP hydrolysis in Ssb. A charged
region within the Zuo1 structure mediates RAC binding to Rpl31, a protein at the ribosomal tunnel
exit (79-81). Ssb binds the unfolded polypeptide, dissociates from the ribosome, and interacts with
NEFs in the cytosol to complete de novo folding activities (45, 82, 83). Although Ssb has the prominent
role in folding newly synthesized proteins and ribosomal interaction, Ssa can fulfill this function in the
absence of Ssb (84). In addition to their de novo folding activities, Ssa and Ssb coordinate with Jjj1
(Hsp40), RAC, and NAC (Nascent Polypeptide-Associated Complex), in the assembly of new ribosomes
(85).
The cytosolic Hsp70 in yeast are also responsible for endoplasmic reticulum (ER) protein
translocation and for nuclear transport across the nuclear membrane (86). Ssa1 binds precursor
proteins prior to their import in to the ER (87) . Ssa1 is also involved during nuclear transport by
targeting protein to the nuclear membrane and during the translocation phase (88). Ssb is exported
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from the nucleus because it possesses a C-terminal nuclear export sequence (NES). Removal of the
NES is sufficient for Ssb to stimulate nuclear transport similar to Ssa. In the nucleus, Ssa also regulates
the transcription factor Hsf1, the master regulator of the HSR. Ssa1 and Ssa2 bind Hsf1 to repress its
activity during non-stress conditions (24) (unpublished data from Sara Peffer, Morano Laboratory).
Protein residents of the ER and the mitochondrion are physically separate from the cytosolic
environment; therefore, they require their own chaperone network with specific Hsp70 machines.
The ER is an undulating organelle where nascent proteins are folded and processed before being
trafficked by Golgi vesicles. Protein processing and the maturation in the ER are facilitated by a
dedicated Hsp70 network. The ER possesses one canonical Hsp70, Kar2 (KARyogamy), four Hsp40s,
and two NEFs (65). Three of the four Hsp40s in the ER are membrane anchored and face the lumen
whereas Scj1 is not anchored and diffusible. Scj1 cooperates with Kar2 to chaperone an array of ER
luminal proteins (89). Translocation into the ER lumen occurs both co-translationally, as proteins are
synthesized, and post-translationally, as a fully synthesized polypeptide released from the ribosome.
During translocation, Kar2 is recruited by Sec63, an Hsp40 protein, to the translocon complex which
stimulates the ATPase activity of the Hsp70 and facilitates the transport of a polypeptide chain across
the ER translocon (90). Lhs1 (Lumenal Hsp Seventy) and Sil1 (Suppressor of the Ire1/Lhs1 double
mutant), are redundant NEFs and function as cochaperones for Kar2 during protein translocation (91).
Perturbations in the ER homeostasis that cause protein misfolding trigger the UPR, causing
proteins to be ejected from the ER in a process known as ERAD (Endoplasmic Reticulum Associated
Degradation). Jem1 (DnaJ-like protein of the ER Membrane) and Scj1 (S. Cerevisiae DnaJ) are Hsp40s
that function redundantly during Kar2-mediated ERAD substrate selection (92). Lhs1 plays a role in
refolding protein aggregates after stress and its substrate binding activity is vital to turnover of ER
proteins through ERAD (93, 94).
Given the different environments in the mitochondrion created by the dual membrane
system and its two compartments, protein folding and quality control requires a dedicated set of
11

chaperones. The Hsp70 machines in the mitochondrion are comprised of three Hsp70-type
chaperones, Ssc1/3 (Stress-Seventy subfamily C) and Ssq1 (Stress-Seventy subfamily Q), five Hsp40type, and one NEF; all of which localize to the mitochondrial matrix (65). The GrpE-like Mge1
(Mitochondrial GrpE) is the sole NEF, so the Hsp70s compete for interaction to fulfill their respective
functions (95, 96).
The primary roles for Ssc1 are in protein translocation into the mitochondrion through interactions
with the translocase complexes, Tom and Tim, followed by protein folding in the matrix (97, 98). Ssc3
is 82% identical to Ssc1 and also associates with unfolded proteins during and after translocation, but
Ssc3 cannot fulfill all the functions of Ssc1 as it cannot complement the lethal ssc1∆ (99, 100). Ssq1
shares 52% identity to Ssc1, and while Ssc1 overexpression can rescue the growth phenotypes of
ssq1∆ during cold stress, Ssq1 overexpression does not fix the translocation defects in cells expressing
an Ssc1 mutant (101). Assembly of FeS clusters in mitochondria requires Ssq1 activity along with the
Hsp40, Jac1 (102). In the mitochondrial matrix, yeast has an Hsp104 homolog known as Hsp78 which
binds and stabilizes unfolded proteins to prevent aggregation (65, 77).

Hsp78 has chaperone

functions that overlap with those of Ssc1 such as maintaining genome integrity and respiration in the
mitochondrion and conferring mitochondrial thermotolerance (77). Hsp70 is conserved throughout
various compartments of the yeast cells to promote protein folding in diverse environments in
coordination with cochaperones that add specificity to the Hsp70 machine.

Sse1/Hsp110 as a nucleotide exchange factor and holdase

First characterized in 1993, the Sse1/Sse2 proteins share high similarity with each other (97%)
and with the Hsp70 protein Ssa1 (70%) (71). Distinct from other NEFs, Hsp110 share similar structure
to Hsp70 and are divergent members of the Hsp70 superfamily. Hsp110, like Hsp70 proteins, is
composed of a nucleotide binding domain (NBD) with an ATP binding pocket, and a substrate binding
12

domain (SBD) at the C-terminus (103) (60) (104). The NBD is followed by a linker that connects it to
the SBD which can be subdivided into a β-domain (β sandwich and loop) and a α-domain (Figure 1-1).
The loop in the SBD β functions as a spacer region between the β-domain sandwich and α-helix
bundle that makes up the α-domain (59).
Unlike the Hsp70s, the NBDs of Sse1 and Sse2 bind ATP but hydrolysis is not required for their
NEF activity (39, 44, 47, 105). ATP binding allows the Sse1 NBD to be in a proper conformation to
interact with Hsp70. The Sse1 α-helical lid domain contacts the Hsp70 NBD in the heterodimer
complex (Figure 1-3) (60, 104). The crystal structure for the Hsp70-Sse1 complex depicts two
chaperones interacting primarily through the NBDs and the Hsp70 SBD in close proximity to the Sse1
β-domain (104, 105). In complex, the Sse1 substrate binding domain remains exposed and potentially
free to bind an unfolded polypeptide, suggesting possible cooperative substrate binding. Whereas the
entire SBD of Hsp70 is known to bind regions of unfolded polypeptides and accelerate substrate
folding (“foldase” activity), a cellular role for the Sse1/Sse2 β-domain has not been found but it is
hypothesized to be a peptide-binding site (103). Sse1 and mammalian Hsp110 are capable of binding
unfolded substrates and can act as a “holdase” in vitro, meaning that they can stabilize unfolded
proteins independently of Hsp70 (106-108). Sse1 exhibits a preference for regions rich in aromatic
residues that differ from the aliphatic residues commonly bound by Hsp70 (30, 109). The ability of
Hsp110/Sse1 to bind unfolded polypeptides in vitro, the unique peptide preference, and the
conformation of the heterodimer complex with Hsp70 suggest the possibility that Sse1 and other
Hsp110s interact with substrate during the Hsp70 folding cycle. It is widely accepted that Hsp110
modulates Hsp70 function through involvement in its ATPase cycle, but it remains disputed if Hsp110
additionally influences Hsp70 substrate targeting. Biochemical studies have implicated the human
Hsp110 as the single NEF that can power a metazoan dissaggregase machine (110-112). Together,
these data support a model wherein Sse1 binds substrate using its SBD to stabilize unfolded proteins
in vivo thus contributing to Hsp70-mediated protein folding by function other than NEF activity.
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Figure 1-3. Crystal structure of Hsc70-Hsp110 complex. Ribbon model of the heterodimer where
Hsp110 is colored in red, yellow, orange, and brown, and Hsp70 is colored in blue tones (104). This
figure was obtained from Schuermann, J. P., J. Jiang, J. Cuellar, O. Llorca, L. Wang, L. E. Gimenez, S. Jin,
A. B. Taylor, B. Demeler, K. A. Morano, P. J. Hart, J. M. Valpuesta, E. M. Lafer, and R. Sousa. 2008.
Structure of the Hsp110:Hsc70 nucleotide exchange machine. Mol Cell 31: 232-243. It was printed
with permission from Elsevier, the owner of Molecular Cell, through license number 4077501097759.
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Sse1 is an abundant and potent Hsp70 NEF that is constitutively expressed, and both SSE1 and
SSE2 are transcriptionally upregulated during stress conditions (113). During heat stress, SSE1 is
upregulated approximately two-fold, and SSE2 transcripts increase by up to twelve-fold (71). Deletion
of SSE1 confers a distinct growth deficiency and a temperature sensitive phenotype, whereas a
combined deletion of non-essential SSE1 and SSE2 is lethal (40, 44, 71). The overexpression of the
cytosolic Snl1∆N or Fes1 NEFs can partially rescue the growth phenotype of sse1∆ cells grown under
optimal conditions but cannot complement the nonviable sse1∆sse2∆ (114, 115). These phenotypes
indicate that Sse proteins perform a unique cellular role that other cytosolic NEFs cannot fulfill. Given
that Sse proteins are unique in their ability to bind unfolded polypeptides, it stands to reason that
their substrate binding functions cannot be rescued by the other cytosolic NEFs.

Biomedical Significance

The chaperone system that coordinates protein quality control during environmental stress
also overcomes the folding barriers so proteins encoded by genes with mutations can properly fold
(116). Protein misfolding and aggregation are linked to many human diseases. Neurodegenerative
disorders such as Alzheimer’s (AD), Parkinson’s (PD), and Huntington’s (HD) disease, and Amyotrophic
Lateral Sclerosis (ALS) are examples of the deleterious effects of protein misfolding and aggregation
(116, 117). AD, HD, ALS and PD are essentially diseases where misfolded proteins form fibrillar
aggregates that are deposited around neurons. Alzheimer’s disease is characterized by amyloid
plaques or neurofibrillary tangles caused by Aβ-peptide or Tau respectively (118) . Lewy body
formations of α-synuclein are commonly found in Parkinson’s disease (3, 118). When the huntingtin
(Htt) protein is mutated with an expansion of CAG repeats that code for polyglutamine stretches,
intracellular inclusion and cytoplasmic aggregates can form to cause the progression of Huntington’s
Disease (118, 119). Patients with ALS have neuronal aggregates formed by various mutant proteins
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some of which are the mutant superoxide dismutase (SOD1) or fused-in-sarcoma (FUS) gene (118,
120-122). Common to all of these diseases is the neuronal impairment that protein misfolding causes
due to cytotoxicity, the age-dependent onset of the disorders, and the eventually fatal course in
patients.
Animal models are currently being used to further our understanding of the molecular
mechanisms that drive these diseases. Stress responses and molecular chaperones, specifically
Hsp110, are potent modifiers of protein aggregation and can alleviate the degenerative effects of the
“gain-of function” toxic species that cause disease (28). In mice, the absence of one of the three
Hsp110 homologs results in accumulation of the toxic hyperphosphorylated form of tau and enhanced
neurodegeneration (123). Furthermore, Hsp110 has proved to be highly effective at preventing
degeneration and toxicity in flies and mammalian cells expressing polyglutamine proteins (124-126).
Similarly, nematodes expressing a mutant human SOD1 demonstrated diminished locomotion and
aggregate accumulation when Hsp110 levels were reduced through RNAi knockdown (127). Hsp110
also localizes with aggregates of polyglutamine proteins and SOD1 mutants in vivo (124, 127). As yet,
the functional role of the Hsp110 β domain in the Hsp70 protein folding process and the physiological
implications of this activity remain unknown.
The work presented here addresses long-standing questions in molecular chaperone research
and expands our understanding of molecular chaperones. It characterizes Hsp110/Sse1, a
cochaperone that is required for function of the ubiquitous Hsp70, through biochemical and genetic
experiments using yeast and fruit fly chaperones. Chapter 3 describes a novel, micro-scale, and semiautomated method to characterize the molecular dynamics of different types of protein complexes in
vitro using a microplate reader. The interactions between Sse1 and unfolded polypeptides and the
physiological implications of this chaperone activity are investigated in chapter 4. Here, I tested the
involvement of Sse1 substrate binding with respect to growth, proteome maintenance, stress
response, Hsp90-mediated activities, and in clearing fatally misfolded proteins. A regulated
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fluorescence affinity (RFA) tag was used to investigate Sse1 roles in maintaining cellular proteostasis
as detailed in chapter 5. Finally, Chapter 6 establishes the biochemical characterization of the
Drosophila melanogaster Hsp110 which can be later utilized to investigate the molecular dynamics in
a huntingtin (Htt with polyglutamine expansions) model of disease.
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Chapter 2: Materials and methods
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Strains, Plasmids and Yeast Culture
All yeast strains are derived from either BY4741 or W303 (Table 2-1). Mutant sse1sbd was
constructed via site directed mutagenesis by PCR using the plasmid p413TEF-FLAG-SSE1 as a template.
This SSE1 allele and the sse1nbd mutant (sse1-G233D, previously described in (128)) were sub-cloned
into the p413TEF vector using SpeI/XhoI restriction sites (129). The plasmids p413TEF-FLAG-SSE1-RFA
and p413TEF-FLAG-RFA were constructed by Julie Heffler (130) .

The Hsc70cb (Drosophila

melanogaster Hsp110) gene was PCR amplified from the plasmid pUAST-Hsc70cb (kind gift from Dr.
Sheng Zhang, UTHealth) and cloned into p413TEF using XbaI/SpeI.
For immunoprecipitation experiments, SSE1 alleles were expressed from the p413TEF
plasmid. A FLAG epitope tag (DYKDDDDK) was added to the 5’ end of the SSE1 or Hsc70cb genes
immediately after the start codon by using primers that included the FLAG-encoding, yeast-optimized
sequence (5’-GACTACAAGGACGACGATGACAAAATG-3’).
Strains expressing the various SSE1 alleles from the endogenous locus (YPL106C) were
constructed by gene replacement (Figure 2-1.A). SSE1 amplicons were generated from plasmids
containing a CYC1 terminator sequence using primers (5’-ATAACTCTGTCCTTGCCGT-3’) and (5’TACTCTGTCAGAAACGGCCTGTACCGGCCGCAAATTAAAGCC-3’) to PCR-amplify from nucleotide +35
relative to the ATG in SSE1 (forward primer) to the 3’ end of the CYC1 terminator and including an
overhang with homology to the LEU2 terminator (reverse primer). The LEU2 cassette was PCRamplified from plasmid DNA using a forward primer that shares homology with the CYC1 terminator
(5’-GCTTTAATTTGCGGCCGGTACAGGCCGTTTCTGACAGAGTAAAATTCTTG-3’) and a reverse primer with
an

overhang

that

shares

homology

with

the

endogenous

SSE1

terminator

(5’-

AATCTTTTTTTAACTATACAGAGAAGATATTAGTATTTCACACCGCATATCG-3’). The two PCR amplicons
were co-transformed into the BY4741 parent strain and successful Leu+ double recombinants were
selected. Individual clones were obtained, verified by PCR amplification of the SSE1-LEU2 junction and
an area internal to SSE1 using genomic DNA, verified by Western blot, and sequenced to ascertain
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correct integration, presence of desired mutations, and absence of additional nucleotide substitutions
(Figure 2-1.B and C).

20

Figure 2-1. Allele recombination to produce Sse1 variant strains. A. Allele exchange for SSE1 variants
including areas of homology between recombinant fragments and genomic DNA in orange, green, and
blue. B. Verification of proper insertion of SSE1 and LEU2 into the yeast genome by PCR1 and PCR2 as
depicted in (A). C. Verification of protein production and proper protein length by immunoblotting
with anti-Sse1 antiserum.
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Table 2-1. Strains used in these studies.
strain and genotype

source

BY4741 MATa ura3Δ leu2Δ his3Δ met15Δ

Open Biosystems

BY4741 sse1∆::kanMX

[Abrams 2014]

BY4741 SSE1:LEU2

this study

BY4741 SSE1nbd:LEU2

this study

BY4741 SSE1sbd:LEU2

this study

BY4741 SSE1:LEU2 sse2∆:: kanMX

Unekwu Yakubu

BY4741 SSE1nbd:LEU2 sse2∆:: kanMX

Unekwu Yakubu

BY4741 SSE1sbd:LEU2 sse2∆:: kanMX

Unekwu Yakubu

BY4741 SSE1-RFA:LEU2 sse2∆:: kanMX

Unekwu Yakubu

W303 MATa ura3-52 trp1 leu2-3,112 his3-11,15 ade2-1 can1-100

[Rothstein 1991]

W303 sse1∆::kanMX sse2∆:: LEU2

[Trott 2005]

BY4741 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 sse1∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1nbd:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1sbd:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1-RFA:LEU2 pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1nbd:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study

BY4741 SSE1sbd:LEU2 sse2∆ pRH2081 (PTDH3-CPY‡-GFP, ADE2 URA3)

this study
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Table 2-2. Plasmids used in these studies.
plasmid

source

pSSA3-lacZ, URA3-based expression plasmid, GPD promoter

[Liu 1999]

pCH-FLAG-RatGR, HIS3-based expression plasmid

[Liu 1999]

pYRP-G2, 2 µ URA3-based expression GRE-lacZ reporter

[Liu 1999]

p413TEF, HIS3-based expression plasmid, TEF promoter

[Mumberg 1995]

p413TEF-FLAG-SSE1, HIS3-based expression plasmid, TEF promoter

[Abrams 2014]

p413TEF-FLAG-SSE1nbd, HIS3-based expression plasmid, TEF promoter

[Shaner 2004]

p413TEF-FLAG-SSE1sbd, HIS3-based expression plasmid, TEF promoter

this study

p413TEF-FLAG-SSE1-RFA, HIS3-based expression plasmid, TEF promoter

Julie Heffler

p413TEF-FLAG-Hsc70cb, HIS3-based expression plasmid, TEF promoter

this study

pProEX-Htb-HIS6-SSE1, inducible bacterial expression plasmid

this study

pProEX-Htb-HIS6-SSE1sbd, inducible bacterial expression plasmid

this study

pProEX-Htb-HIS6-SSE-RFA, inducible bacterial expression plasmid

this study

pProEX-Hta-HIS6-Hsc70cb, inducible bacterial expression plasmid

this study
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Hsf1 activity was measured with strains harboring plasmid pSSA3HSE-lacZ as described (131,
132). For experiments testing CPYǂ-GFP degradation, strains were constructed using pRH2081
(generous gift from Dr. Randy Hampton, University of California, San Diego), a plasmid that carries
TDH3-driven CPY‡-GFP (133). The integrative plasmid was linearized using restriction endonuclease
Van91I and transformed into indicated strains with Ura+ selection.
To assess growth and complementation, cells were spotted on appropriate solid medium with
a starting concentration of OD600=1.0 and serially diluted 1 in 10. Cultures were incubated at 15, 30,
34, 37, 39 ᵒC, or in the presence of chemical compounds (formamide or trimethoprim) for 2-4 days at
which point plates were photographed.
Cells were grown at 30 ᵒC at a starting OD600 of 0.05 with shaking while absorbance readings
were detected every 15 minutes using a Synergy MX Microplate Reader (BioTek). Doubling time was
calculated by plotting data points from a 16-hour growth curve. GraphPad Prism v.6 (GraphPad
Software, La Jolla, CA) was used to determine the doubling time based on the log phase growth of
each culture using an exponential growth equation.

Protein Purification
Purified firefly luciferase (Sigma L-9506), citrate synthase (Sigma C-2360), and rhodanese
(Sigma R1751) were obtained from Sigma Chemical Corp. (St. Louis, MO). Sse1 was purified from
Escherichia coli BL21 (DE3) by metal affinity chromatography followed by size exclusion
chromatography as described in (134). Hexa-histidine tagged Sse1 was purified from E. coli by
chemical lysis (Bug Buster, Millipore) in buffer B (50 mM Tris pH 7.5, 200 mM NaCl, 2 mM MgCl2, 5
mM imidazole). The cell lysate was incubated with His-Pur Cobalt Resin (Thermo Scientific), washed
with buffer B and C (50 mM Tris pH 7.5, 600 mM NaCl, 2 mM MgCl2, 10 mM imidazole), and eluted
with Buffer E (50mM Tris pH 7.5, 700 mM NaCl, 2 mM MgCl2, 200 mM imidazole). Sse1-containing
elution fractions were combined, buffer exchanged (25 mM Tris pH 7.5, 100 mM NaCl), and further
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purified by size exclusion chromatography using Sephacryl S-100 (GE Healthcare). Purification of
Hsc70cb was performed following the same protocol as for Sse1.

Nucleotide Binding Assay
Fluorescently labeled nucleotide, N6-(6-Amino)hexyl-ATP-5-FAM (ATP-FAM) (provided by Dr.
Jason Gestwicki; Jena Bioscience, Jena, Germany), was incubated at a concentration of 20 nM with
increasing amounts of Sse1 or Sse1sbd chaperone in buffer (25 mM Tris-HCl, pH7.5, 100 mM NaCl, 5
mM MgCl2, 50 mM KCl, 5% glycerol) for 30 minutes at room temperature as described (135).
Fluorescence polarization was measured (excitation λ: 485 nm emission λ: 535 nm) using a
SpectraMax M5 plate reader (Molecular Devices). Equilibrium binding constants were calculated using
a saturation binding one-site equation via GraphPad Prism v.6 (GraphPad Software, La Jolla, CA).
These experiments were conducted in the laboratory of Dr. Jason Gestwicki (University of California
San Francisco) with use of their equipment and reagents.

Nucleotide Exchange Assay
The HSPA8 (Hsc70) protein was a generous gift from Dr. Betty Craig (University of Wisconsin,
WI). HSPA8 (70 µg) was loaded with 100 µCi of α-32P-ATP in a total volume of 120 µL of complex
buffer (25 mM HEPES-KOH pH 7.5, 100 mM KCl, 11 mM MgOAc, and 25 µM ATP) for 30 minutes at 4
°C, and HSPA8-32P-ATP complex was obtained by centrifugation through a Microspin G-25 column (GE
Healthcare, Chicago, IL). Labeled HSPA8 (7.8 µg) was incubated in the presence or absence of 5 µg of
NEF at 30 °C. At designated times, the HSPA8-NEF reactions were again passed over G-25 columns to
separate from released nucleotide. Radiolabeled nucleotide that remained bound to HSPA8 was
determined using a TRI-CARB 2900TR Liquid Scintillation Analyzer and normalized to counts obtained
at time zero.
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Protein Aggregation Assay
Aggregation assays were conducted in a Synergy MX Microplate Reader. Rhodanese and
citrate synthase were incubated in denaturing buffer (6 M guanidinium chloride, 5 mM dithiothreitol)
at concentrations of 13.3 and 11.6 uM, respectively for 1 hour at room temperature (136) (137) (138).
Refolding buffer (25 mM Tris pH 7.5, 100 mM NaCl) or denaturing buffer (6 M guanidinium chloride, 5
mM dithiothreitol) were pre-equilibrated at 25 °C in a 96-well, half area, UV-transmissible plate
(675801, Greiner Bio-One) for 5 min and baseline absorbance was determined. After equilibration,
chemically denatured substrate was added to a final concentration of 150, 300, 600, or 900 nM into
the refolding buffer or 900 nM into the denaturing buffer to a final volume of 180 µL. The samples
were mixed thoroughly and absorbance was measured at 320 nm at 30-second intervals for 30
minutes. Changes in absorbance were calculated after subtracting baseline absorbance at time zero,
and all experiments with a given substrate were performed concurrently on a single microplate.
To compare chaperone capabilities of Sse1, Sse1sbd, or Hsc70cb, substrate aggregation was
measured as described in (134) with the following modifications. Stock concentrations of firefly
luciferase or citrate synthase were incubated in denaturing buffer for 1 hour at room temperature. In
a 96 well, half area, UV-transmissible plate refolding buffer alone, varying concentrations of
chaperone in refolding buffer, or denaturing buffer were pre-equilibrated at 25 °C for 5 minutes and
baseline light scattering was determined. After equilibration, chemically denatured substrate was
added to each sample at a final concentration of 200 nM into the refolding buffer to a final volume of
180 µL. The samples were mixed vigorously for 5 seconds and aggregation was measured at 320 nm at
30-second intervals for 30 minutes. Changes in absorbance were calculated after subtracting baseline
absorbance at time zero.
To assess fractionation of protein into soluble and insoluble aggregates, samples (175 µL)
were taken from the endpoint of the substrate aggregation experiments and subject to centrifugation
at 16,000 x g for 4 minutes. 170 µL were recovered as the supernatant or soluble fraction. The lower 5
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µL fraction was considered the pellet or insoluble fraction and volume was normalized to 170 µL with
the addition of refolding buffer. 30 µL of each fraction were separated by 12% SDS-PAGE and stained
with Coommassie Blue. Band densities were calculated using Image Studio Software (Li-Cor
Biosciences, Lincoln, NE).

Immunoblotting
Cultures were grown overnight and secondary cultures started and allowed to grow to an
OD600 of 0.8 at which point cells were shifted to 37 °C or maintained at 30 °C for 6 hours. Cells were
collected and processed for protein lysates. Sse1 protein levels were detected by immunoblot using
anti-Sse1 antiserum (generous gift from Dr. Jeff Brodsky, University of Pittsburgh, PA) and antiphosphoglycerate kinase (PGK; Invitrogen, Carlsbad, CA) was used as a loading control. Band analysis
was performed using Image Studio Software and Sse1 levels were normalized to the levels of PGK.
Hsp90 levels in were assessed in cells grown at 30 °C by immunoblot using anti-Hsp90 (generous gift
from Dr. Avrom Caplan, CUNY, NY) with anti-Sse1 and anti-PGK as internal controls. Band analysis was
performed using Image Studio Software. Sse1 and Hsp90 levels were normalized to PGK levels.

Immunoprecipitations
Sse1 proteins were expressed with an N-terminal FLAG-tag. Protein extracts were prepared
from 30 mL of cultures grown at 30 °C or 37 °C for 6 hours. Protein lysates were incubated with 40 µL
of M2 resin (Sigma) in TEGN (20 mM Tris-HCl, pH 7.9, 0.5 mM EDTA, 10% glycerol, 50 mM NaCl) at 4
°C for two hours. After washing with 4 mL of buffer, the resin was incubated with 40 µL of FLAG
peptide for 25 minutes at room temperature to elute the FLAG-Sse1 complexes. Immunoprecipitated
proteins were analyzed by SDS-PAGE and Coommassie Stain. Band analysis was performed using
Image Studio Software and the co-immunoprecipitation efficiency of Hsp70 was calculated relative to
the amount of Sse1 immunoprecipitated.
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The GFP immunoprecipitation was performed using Sepharose beads conjugated with antiGFP monoclonal antibody. Protein lysates from 35 mL of cells at log phase were obtained and
incubated with anti-GFP (Thermo Fisher Scientific Inc., Waltham, Massachusetts) in buffer (TEGN,
protease inhibitor, 0.1% Triton X-100). The protein lysate/antibody solution was incubated with
protein A sepharose (Sigma-Aldrich, St. Louis, MO) followed by washing. Immunoprecipitated proteins
were eluted in 40 µL Laemmli sample buffer at 80ᵒ C. Samples were visualized by SDS-PAGE and
Coommassie Stain.

Glucocorticoid Receptor Activation
The various Sse1 strains were transformed with plasmids pCH-Flag-RatGR and pYRP-G2
expressing the glucocorticoid receptor protein and a GRE-lacZ transcriptional reporter, respectively
(131). Cells grown to mid-logarithmic phase were treated with DMSO only (-DOC) or 10 µM
deoxycorticosterone in DMSO (+ DOC) for 1.5 hours. β-galactosidase activity was measured by adding
50 µL of cell suspension at OD600 0.4 and 50 µL of Beta-Glo reagent (Promega, Madison, WI) and
incubating for 30 minutes at 30 °C followed by luminescence detection using a Synergy MX Microplate
Reader.

CPYǂ-GFP Degradation Assay
To track the degradation of the CPYǂ-GFP protein in vivo, cells were grown to mid-logarithmic
phase, treated with 100 µg/mL cycloheximide, and 10 mL of culture were collected at 0, 1, and 2
hours. Denatured protein extracts were prepared using a glass bead lysis method with SUME buffer
(1% SDS, 8M Urea, 10mM MOPS, pH 6.8, 10mM EDTA). The CPYǂ-GFP protein was detected by
immunoblot using anti-GFP (Roche, Basel, Switzerland) and anti-PGK was used an internal control. In
parallel experiments, CPYǂ-GFP-expressing cells were collected immediately after treatment at 0, 45,
and 90 minutes and visualized using an Olympus IX81-ZDC inverted microscope as described in (14).
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The experiments to assess CPYǂ-GFP aggregates in the SSE1-RFA strain were conducted by
growing the different strains in the absence or presence of 500 µM trimethoprim for 6 hours or more.
When the cells reached log phase, they were treated with cycloheximide and cells were analyzed via
immunoblot or by microscopy at the times indicated.

Protein similarity analysis
Hsc70cb and Sse1 were compared to determine protein similarity using the NCBI protein
blast software. For the Hsc70cb query, the protein sequence used was Hsc70Cb (isoform A) obtained
from uniprot.org (http://www.uniprot.org/uniprot/Q9VUC1). The Sse1 (YPL106C) amino acid
sequence was obtained from the Saccharomyces Genome Database using reference strain S288C
(http://www.yeastgenome.org/locus/S000006027/protein).

Statistics
The data represented in the graphs is the mean of independent replicates and the error bars
represent ± standard deviation. Statistical analysis was performed using a student’s t-test.
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Chapter 3: Semi-automated microplate monitoring of protein polymerization and aggregation

Note: This chapter was derived from work that is published in the Journal of Analytical Biochemistry.
Garcia VM, Rowlett VW, Margolin W, Morano KA. Semi-automated microplate monitoring of protein
polymerization and aggregation. Anal. Biochem. 2016 Sept. 508: 9-11. I acquired the data presented
in this chapter. FtsZ polymerization experiments were performed by Veronica Rowlett, Ph.D., in
collaboration with the laboratory of William Margolin, Ph.D. These data are thus excluded from this
chapter. Permission to use previously published material was granted by Elsevier, owner of Analytical
Biochemistry, through license number 4063260221106.
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Introduction

Static light scattering (SLS) techniques such as multi-angle (MALS) and right-angle (RALS)
measure the light deflected from particles in solution that are larger than the wavelength of the light
emitted. Such methods typically require expensive fluorimetry equipment, consume large amounts of
purified protein, and may be unsuitable for high-throughput assays (136, 139). For example, a
fluorimeter equipped with a stirrable, temperature-controlled cell holder is required for RALS analysis,
and the cost of such equipment may be prohibitive for many laboratories. Furthermore, such devices
are limited to single cell measurements, and the need to maintain solution homogeneity through
mechanical stirring dictates mL-scale volumes per experiment. If proteins are tested at nano- or
micromolar concentrations, significant amounts of purified or purchased proteins are required.
Described here is an alternative method for tracking the formation of aggregates of proteins
that yields results comparable to SLS. This approach utilizes a microplate reader with temperature
control, along with 96-well half area microplates that allow for multiple reactions to be analyzed
simultaneously in a low reaction volume. While previous applications of microplate technology for
following protein dynamics in high-throughput molecular screens have been described (66, 140, 141),
I demonstrate here the sensitivity and range of this technique by measuring protein aggregation of
three traditional chaperone substrates and aggregate prevention by a molecular chaperone. The
method described here measures, in real-time, the increase in turbidity that occurs as high molecular
weight protein complexes or aggregates form in an aqueous buffer. Our overall goal was to show that
a method for sensitive, rapid and reproducible comparative monitoring of protein assembly dynamics
in small volumes can be accessible to molecular biologists.
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Results

Various biological applications require the study of large protein complexes. For example,
tracking the formation of aggregates allows the characterization of molecular chaperones. By
monitoring the aggregation of model substrates in the presence of chaperones, we can understand
the substrate specificity, molecular dynamics, and environmental requirements for chaperone
function. Traditionally, methods like MALS or RALS are utilized to detect dynamics of aggregate
formation and chaperone activity. A sample is placed in the path of emitted light, and these
techniques directly measure light that is scattered at multiple designated angles for MALS or at a right
angle from the light source in the case of RALS. While these methods can produce a lot of information
about the given sample, such as the absolute molar mass or average molecular size of the molecules
in the solution, the instruments required to conduct this type of analysis are expensive and not widely
available. Initially, I characterized protein aggregation and chaperone activity using RALS but the
requirement of large volumes of protein at high concentrations became prohibitive (equipment
provided by the laboratory of Dr. Vasanthi Jayaraman, UTHealth). The alternative method I describe
here can track the formation of aggregates by measuring absorbance. The reduction in light
transmittance is detected as aggregates increase and grow in a solution (Figure 3-1.A). Aggregation is
monitored in real time, using smaller protein volumes, and across multiple samples concurrently.
Chaperones detect unfolded proteins and prevent their aggregation by stabilizing unfolded
polypeptides until native conformations are achieved (5). Chaperones differ in substrate specificity
and their molecular interactions with clients, and various aggregation-prone model proteins including
firefly luciferase, rhodanese, and citrate synthase have been used to elucidate biochemical features of
chaperone function and specificity (107, 137, 142-144). Due to the irreversible side reactions that
occur during unfolding, these, and other commonly employed substrates, rapidly aggregate when
diluted from a denaturing solution into a non-denaturing buffer unless accompanied by molecular
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chaperones (138, 145). Firefly luciferase was chemically denatured (denaturing buffer: 6 M
guanidinium chloride, 5 mM dithiothreitol) and diluted into the refolding buffer (25 mM Tris pH 7.5,
100 mM NaCl) or denaturing buffer. The samples were mixed thoroughly while making sure to not
introduce air bubbles and transmittance was measured at 320 nm at 30 second intervals for 45
minutes at 25 ᵒC. Changes in transmittance were calculated after subtracting baseline transmittance
at time zero. Figure 3-1.B demonstrates that denatured firefly luciferase remains denatured in the
presence of guanidinium chloride and that aggregation can be detected in the refolding buffer. As an
alternative approach, the samples that were monitored during the aggregation experiments were
collected and centrifuged to isolate the soluble firefly luciferase and the insoluble substrate
aggregates into the supernatant and pellet respectively (106). This technique served to confirm that
the increase in absorbance that was detected for the firefly luciferase in refolding buffer was due to
substrate aggregation. Notably, transmittance changes due to the aggregation of firefly luciferase
correlated with high-speed fractionation of the substrate into soluble (supernatant) and insoluble
fractions (pellet) (Figure 3-1.C). Also, the firefly luciferase diluted further into denaturing buffer did
not track an increase in transmittance and remained soluble, likely as monomers, as indicated by the
differential centrifugation.
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Figure 3-1. Monitoring aggregation of firefly luciferase. A. Aggregates are monitored through a
decrease in light transmittance. B. Aggregation of 200 nM chemically denatured firefly luciferase (FFL)
is monitored in denaturing buffer (DC) or refolding buffer (AC). Average data points are plotted (n=4)
with a standard deviation ≤ 0.003. C. One representative image of an SDS-PAGE gel and Coommassie
stain visualizing the fractionation of soluble (S) or aggregated (P) FFL by centrifugation after 30
minutes.

34

The aggregation of chemically denatured rhodanese and citrate synthase was monitored at
various concentrations (136-138). Refolding buffer or denaturing buffer were pre-equilibrated at 25°C
in a 96-well, half area plate for 5 min and baseline transmittance was determined. After equilibration,
denatured substrate was added to a final concentration of 150, 300, 600, or 900 nM into the refolding
buffer or 900 nM into the denaturing buffer and transmittance was measured at 320 nm at 30 second
intervals for 30 minutes. Changes in transmittance were calculated after subtracting baseline
absorbance at time zero, and all experiments with a given substrate were performed concurrently on
a single microplate. Denatured rhodanese aggregation was tracked by measuring absorbance at 320
nm (Figure 3-1. B). Our results indicate that this method successfully detects increasing aggregation
over time, using concentrations of denatured rhodanese in line with those previously published (136,
144). Similarly, the results obtained using chemically denatured citrate synthase were similar to those
previously published (106, 143). Aggregates formed by either substrate were detected at
concentrations as low as 150 nM and the change in transmittance increased with greater substrate
concentrations, consistent with increased light scattering due to the formation of aggregates (Figure
3-2. B).
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Figure 3-2. Aggregation of model chaperone substrates rhodanese and citrate synthase. A.
Rhodanese was denatured in 6 M guanidinium chloride + 5 mM DTT for 45 minutes. Denatured
rhodanese was diluted into 180 µL of assay buffer (25 mM TRIS pH7.5 + 100 mM NaCl) and
aggregation was measured at 25 °C by change in absorbance using a Biotek Synergy MX plate reader.
Average data points are plotted (n=4) with a standard deviation ≤ 0.003. B. The aggregation of citrate
synthase was measure using the same method as for rhodanese. Average data points are plotted
(n=2) with a standard deviation ≤ 0.003.
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I assessed whether this microplate reader assay would be adaptable to study the ability of
molecular chaperones to modulate protein aggregation. Molecular chaperones help to maintain
cellular proteomes by interacting with unfolded or partially folded proteins, preventing their
aggregation and stabilizing polypeptides until native conformations are achieved (3). Citrate synthase
is recognized as a substrate by the Hsp110 class of chaperones that stabilize the unfolded protein to
prevent aggregation (142, 146). I analyzed the aggregation dynamics of citrate synthase in the
presence of the yeast Hsp110 chaperone, Sse1. Hexa-histidine tagged Sse1 was purified from
Escherichia coli and used for analysis of protein aggregates in the presence of a chaperone. The
protein solutions must be equilibrated to the temperature and buffer conditions of the assay, as an
abrupt shift in buffers or temperature can result in an artificial increase in absorbance. Each sample
was equilibrated in refolding buffer with 0, 100, 200, 400, or 800 nM Sse1 or denaturing buffer in the
absence of Sse1 at 25° C in a 96-well, half area plate for 5 min while absorbance was measured. After
equilibration, chemically denatured citrate synthase was added to 200 nM, chosen as a minimal
aggregating substrate concentration, into the refolding buffer or into the denaturing buffer, with and
without Sse1, to a final volume of 180 µL. The samples were mixed thoroughly for 5 sec and
absorbance was measured at 320 nm every 30 sec for 30 min at 25°C. Consistent with reported
results, increasing Sse1 concentrations promote solubility of the aggregate-prone substrate (Figure 33. A). Notably, absorbance changes due to the aggregation of citrate synthase correlated with transfer
of the substrate from a high-speed sedimentable fraction to a soluble state as assessed by SDS-PAGE
of endpoint samples followed by Coommassie Blue staining (Figure 3-3. B).
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A

B

Figure 3-3. Monitoring aggregate prevention of citrate synthase and protection by Sse1. A. Citrate
synthase (CS) was denatured same as described and diluted into assay buffer with increasing
concentrations of chaperone. Average data points are plotted (n=3) with a standard deviation ≤ 0.003.
B. Samples were collected from the end point of experiment in (A) and the soluble and aggregated
fractions of CS and Sse1 were separated into supernatant and pellet through differential
centrifugation followed by analysis on SDS-PAGE and Coommassie stain.

Discussion
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I have described an accessible, low- to high-throughput alternative to SLS that provides similar
results at levels of detection comparable to single-cell analysis. In this work, I have demonstrated the
applicability of this method to study the aggregation of three different model substrates that are
routinely used to characterize chaperone activity (firefly luciferase, citrate synthase, and rhodanese).
The method I presented has some limitations when compared with traditional MALS or RALS. It
should be noted that a few seconds of data are lost during insertion and calibration of the plate when
using a plate reader, making this technique unsuitable for analysis of initial burst dynamics. However,
kinetic analyses to determine aggregation parameters may be undertaken using standard calculations
(147). Further, the method adaptation I describe cannot provide information about molecular weight
or size of the aggregates. Nonetheless, the technique presented here is a simpler, quicker, and more
efficient way to simultaneously compare the dynamics of high molecular weight protein assemblies
across multiple samples and conditions. As microplate readers can be outfitted with both injection
systems and ambient temperature controls, this approach can allow for concurrent analysis of
multiple experimental variables.
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Chapter 4: Substrate binding by the yeast Hsp110 nucleotide exchange factor and molecular
chaperone, Sse1, is not obligate for its biological activities

Note: This chapter was derived from work performed by Veronica Margarita Garcia. The data
discussed regarding the refolding and disaggregating capacity of Sse1 and Sse1sbd is the work of
Nadinath Nillegoda, Ph.D. with recombinant Sse1 proteins supplied by Garcia, as a collaborative
effort with the laboratory of Bernd Bukau, Ph.D. Because this work was not performed by Garcia, the
data have been excluded.
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Introduction

Proteins must fold into a proper three-dimensional configuration, or native state, to execute
their intended functions. Proteomic stressors such as exposure to harmful chemicals, oxidative stress,
and aging can inhibit protein folding, disrupt protein homeostasis and result in cell death and human
disease (3). Misfolded proteins or amyloid aggregates contribute to the development or progression
of neurodegenerative disorders; Alzheimer’s disease, Huntington’s disease and Parkinson’s disease
are all fundamentally diseases of protein misfolding (116, 120). Cell survival during and after stress
conditions is promoted by molecular chaperones that optimize protein folding by stabilizing folding
intermediates until native conformations have been obtained. The highly conserved Hsp70 chaperone
is integral to protein biogenesis, quality control, and degradation of terminally misfolded proteins
(53). The Hsp70 protein folding cycle is ATP-dependent and is regulated by co-chaperones such as
Hsp40s and nucleotide exchange factors (NEFs) that stimulate ATP hydrolysis and exchange,
respectively (148, 149). The budding yeast Saccharomyces cerevisiae expresses three classes of
cytosolic NEFs all with human orthologs: the Hsp110-type proteins Sse1/Sse2, the HSPBP1-type
protein Fes1 and the BAG-1-type protein Snl1 (150). SSE1 deletion results in slow growth and
temperature sensitivity, whereas a combined deletion of SSE1 and SSE2 is lethal despite the presence
of Fes1 and Snl1, suggesting a potentially unique role for the Hsp110 proteins (151, 152). The Hsp110
proteins are highly homologous to Hsp70 composed of an amino-terminal nucleotide binding domain
(NBD) and a substrate binding domain (SBD) that is further subdivided into a β-sandwich domain and
an α-helical “lid” domain (59, 60, 104). Distinct from Hsp70, Sse1/2 bind ATP which stabilizes the NBD,
but catalytic activity (ATP hydrolysis) is not required to functionally complement the null mutant in
vivo or to accelerate Hsp70 nucleotide exchange in vitro (40, 44, 45, 47, 112).
While the NEF function of Hsp110/Sse is well established, possible biological roles for
substrate binding by the SBD remain speculative. Crystal structures of the Hsp70-Sse1 complex depict
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the Hsp70 SBD in close proximity to the Sse1 β-domain, suggesting possible cooperative substrate
binding (60, 104). The Hsp110 SBD is structurally similar, but not identical, to that of Hsp70, and it is
suggested that it binds peptides much like Hsp70 through interactions with both β-sheets and the
connecting loops within the β-domain (106-108). Hsp110s are highly efficient at blocking aggregation
of misfolded substrates in vitro (defined as “holdase” activity) and Sse1 possesses a unique peptide
binding preference for regions enriched in aromatic amino acids, relative to the yeast Hsp70, Ssa1 (30,
109). While contributions to substrate selection and targeting to Hsp70 by Hsp40 co-chaperones are
established, it remains unclear if the holdase activity of Sse1 or other Hsp110 chaperones contributes
to Hsp70-dependent functions in vivo (57). Deletion mutagenesis to remove the Sse1 SBD is
complicated by the fact that carboxyl-terminal deletions render the protein unstable, and that the αhelical domain is required for heterodimerization with Hsp70 (44, 60, 104). Site-specific mutagenesis
targeting residues in the Sse1 substrate binding domain modeled on the peptide binding site of the
bacterial Hsp70, DnaK, was likewise unsuccessful (60). Yeast cells lacking Sse1 are defective in folding
of newly synthesized polypeptides and degradation of some misfolded proteins (40, 132, 153).
However, overexpression of either Fes1 or a soluble, truncated mutant form of the normally ERassociated NEF Snl1, both of which lack demonstrated holdase activities, partially suppresses these
phenotypes (39, 114). In contrast, other NEFs cannot substitute for Hsp110 in protein disaggregation
reactions, suggesting that Hsp110 possesses specific properties that could be linked to its unique
substrate binding domain (54, 110, 112, 154).
In this study, I generated an Sse1 variant that separates, for the first time, the nucleotide
exchange and substrate binding functions of this chaperone. Multiple targeted single-residue
substitutions in the β-sandwich region of the SBD were introduced to generate a novel mutant
(Sse1sbd) that exhibits greatly reduced aggregation-preventing activity while retaining nucleotide
binding and Hsp70 nucleotide exchange potency. Strikingly, Sse1sbd was competent to restore growth
to cells lacking SSE1 and/or SSE2, to promote disaggregase activity in a reconstituted in vitro system,
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and to support Hsp70-dependent signal transduction and protein degradation while exhibiting minor
defects in stress resistance and protein quality control. The data presented here suggest that the
substrate binding function of Sse1, despite being conserved among the eukaryotic Hsp110 proteins,
plays a minor role in maintaining protein homeostasis in the yeast system.

Results

I generated a novel Sse1 substrate binding domain (SBD) mutant based on previous structural
studies (60, 109) that indicated the region mutated could be within a putative peptide binding site
(Figure 4-1.A). This putative substrate binding defective mutant (Sse1sbd) includes four specific amino
acid substitutions (L433A, N434P, F439L, and M441A) within the L3,4 region of the β-sandwich domain
in Sse1. I first verified that the introduced mutations exclusively targeted substrate binding while
maintaining proper nucleotide binding in the NBD. Recombinant proteins were purified from E. coli to
conduct in vitro experiments (Figure 4-2). ATP binding was measured with fluorescently labeled
nucleotide through fluorescence anisotropy. When compared to the wild-type protein, Sse1sbd bound
FAM-ATP with approximately the same affinity (Kd of 12.1 µM ±1.9 for Sse1sbd, vs. 8.6 µM ±1.4 for
wild-type Sse1, Figure 4-1.B). These values are consistent with previously reported affinities measured
using a different fluorescently labeled nucleotide, MABA-ATP (2.1 µM ±0.6) (47). It was also essential
that the mutant protein could still function as a nucleotide exchange factor (NEF) for Hsp70. I
measured the exchange of α-32P-ATP loaded onto human Hsc70 (HSPA8) in the absence of NEF, or in
the presence of Sse1 or Sse1sbd, and found no discernable difference in the accelerated exchange
rates (Figure 4-1.C). Together these results demonstrate that Sse1sbd retains critical nucleotide-binding
and NEF features of the Hsp110 chaperone.
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Figure 4-1. Novel Sse1 substrate binding mutant retains Hsp70 nucleotide exchange capacity. A.
Crystal structure of the Sse1 β-domain with amino acids selected for mutations highlighted in red
(109). B. Fluorescence anisotropy was performed with increasing concentrations of chaperone (Sse1
or Sse1sbd) binding fluorescently labeled ATP-FAM. (n=3) C. Nucleotide exchange activity assays using
HSPA8 (Hsp70) pre-bound to α-32P-ATP in the presence or absence of Sse1 (n=2). Error bars in all
panels indicate standard deviation.
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Figure 4-2. Purification of recombinant Hexa-histidine tagged Sse1 proteins. A. Recombinant HisSse1 and His-Sse1sbd purified from E. coli visualized on an SDS-PAGE gel using Coommassie stain.
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To assess whether substrate binding was impaired as predicted, I measured the ability of Sse1
and Sse1sbd to prevent the aggregation of chemically denatured firefly luciferase (FFL) using an
established assay system (134). Whereas wild-type Sse1 effectively reduced FFL aggregation relative
to that observed in the absence of chaperone, the Sse1sbd protein was significantly impaired in
aggregate prevention (Figure 4-3.A). To verify that the spectrophotometric assays reflected substrate
aggregation into insoluble material, end-point samples were analyzed by differential centrifugation
followed by SDS-PAGE and densitometry quantitation (Figure 4-3.B). Sse1 maintained 72% of FFL in a
soluble state after 30 min, whereas only 39% of FFL is soluble in the presence of Sse1sbd as the
chaperone. Similar results were obtained with citrate synthase as the unfolded substrate (Figure 44.A-C). Increasing the ratio of Sse1 to FFL or CS allowed for better aggregate prevention, whereas
increasing the ratio of Sse1sbd only mildly improved protection of the denatured substrate (Figure 43.C and Figure 4-4.D). These data indicate the novel Sse1sbd mutant is defective in its ability to
passively chaperone unfolded proteins while NEF function and nucleotide binding remain intact.
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Figure 4-3. Sse1 substrate binding domain mutant exhibits impaired chaperone holdase activity
towards firefly luciferase (FFL). A. Substrate aggregation experiments were conducted using
chemically denatured firefly luciferase (FFL) (200 nM) diluted into refolding buffer without chaperone,
with Sse1 (400 nM), or with Sse1sbd (400 nM). FFL diluted further into denaturing buffer was used as
a control. B. Differential centrifugation analysis of FFL aggregation in the absence of chaperone or
with Sse1 or Sse1sbd after a 30 min holdase assay. Samples were visualized by SDS-PAGE followed by
Coommassie stain, and scanning densitometry quantitation was performed to determine FFL
aggregation under each condition. Graph represents the average FFL that remained soluble in each
sample ± standard deviation (n=4) (p< 0.01). C. Analysis of holdase experiments using denatured FFL
with varying ratios of chaperone were quantified using the endpoint degree of aggregation detected
as in (B). Graph represents the average FFL that aggregated in each sample (n=2). Error bars represent
± standard deviation (p< 0.05).
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Figure 4-4. Sse1 substrate binding domain mutant exhibits impaired chaperone holdase activity
towards citrate synthase (CS). A. Substrate aggregation experiments conducted using chemically
denatured CS (200 nM) diluted into refolding buffer without chaperone, with Sse1 (200 nM), with
Sse1sbd (200 nM), or with BSA (400 nM) as a non-chaperone control. B. Analysis of CS aggregation in
the absence of chaperone in refolding or denaturing buffer or in the presence of different chaperones
after 30 min in a holdase assay via differential centrifugation. Samples were analyzed via SDS-PAGE
and Coommassie stain. C. Analysis of holdase experiments using denatured CS with varying ratios of
chaperone using the endpoint amount of aggregation detected (n=2). Errors bars represent ±
standard deviation. Data is not statistically significant between Sse1 and Sse1sbd.
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Hsp110 however, when compared to other NEFs, has been demonstrated to boost the
aggregate solubilization activity of the Hsp70-based disaggregase machine (54, 110, 154, 155).
Nillegoda therefore tested if the substrate binding function of Sse1 is required in this capacity. As a
first step, he tested if substrate binding by Sse1 was important for re-folding of thermally denatured
monomeric FFL. FFL was heat denatured in the presence of HSPA8 (Hsc70), DnaJB1 (Hsp40), and
Hsp26 for 10 min at 42 °C (110). The samples were shifted to 30 °C and a nucleotide regeneration
system was added. Refolding of FFL was measured in the presence of no NEF, Sse1, Sse1sbd, or HSPH2
(human Hsp110) as a control. It has been previously established that yeast and human Hsp110s are
functionally interchangeable (110). Sse1 and Sse1sbd were observed to aid Hsp70/Hsp40 equally in
successful refolding of FFL (data not shown). To test if the substrate binding function of Sse1 might be
necessary for the more difficult task of disaggregating FFL, aggregates were formed by FFL heat
denaturation (15 min, 45 °C) in the presence of Hsp26, and the aggregates were mixed with a cocktail
of chaperones containing HSPA8, DnaJB1, and no NEF, Sse1, Sse1sbd, or HSPH2. Again, substrate
binding deficient mutant Sse1sbd functioned with Hsp70/Hsp40 as effectively as the wild-type Sse1 or
the HSPH2 (human Hsp110) control (data not shown). All three Hsp110 proteins were able to
reactivate over 40% of the aggregated FFL within the two-hour time course. The data indicate that
Sse1 holdase activity is not obligatory for effective refolding or dissagregase activity of at least the
model substrate FFL.
Sse1 is a critical component of the protein quality control machineries. Indeed, sse1∆ cells
demonstrate significant growth deficiencies including temperature sensitivity, and sse1∆sse2∆ cells
are unviable (151). Furthermore, Sse1 and Sse2 are unique among known cytosolic NEFs for
possessing substrate binding activity, raising the possibility that this activity is important in vivo. To
test this hypothesis, I began by determining the expression of Sse1sbd to ensure that the introduced
mutations did not affect its stability in vivo. At 30 °C and 37 °C, plasmid-borne Sse1, Sse1sbd and a
previously described NEF-defective mutant carrying the G233D mutation (here designated Sse1nbd),
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were expressed at similar levels, both slightly higher than endogenous Sse1 (Figure 4-5.A and B). I also
wanted to ensure that Sse1sbd retained interaction with the yeast cytosolic Hsp70s (Ssa and Ssb) to
function as a NEF in vivo. All Sse1 proteins were expressed with a FLAG-tag fused to the N-terminus
and co-immunoprecipitations were performed (44). Sse1sbd was found to associate with the cytosolic
Hsp70s, Ssa and Ssb, at both temperatures in a manner indistinguishable from wild-type Sse1 (Figure
4-5.C and D).
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Figure 4-5. Sse1sbd is stable and interacts with endogenous yeast Hsp70 proteins in vivo. A. Protein
lysates from cells expressing the indicated SSE1 alleles and cultured at 30 °C or 37 °C were analyzed by
immunoblot to determine expression levels and stability (n=3). B. Quantitative analysis of the
immunoblots in (A). Error bars represent ± standard deviation.

C. Co-immunoprecipitation

experiments using FLAG-tagged Sse1 (labeled with a closed circle) variants were performed to assess
interactions with endogenous Ssa and Ssb proteins (labeled with an open circle) (n=3). Samples were
analyzed via Coommassie stain on an SDS-PAGE. D. Quantitative analysis of band densities in (C). Error
bars represent ± standard deviation.
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Given that Sse1sbd displayed normal stability and retained Hsp70 interaction at both standard and
heat shock temperatures, I next assessed the contribution of substrate binding to Sse1 functions in
vivo. As previously mentioned, the sse1nbd allele contains the mutation G233D which renders it unable
to bind nucleotide, interact with Hsp70, or act as a NEF (40, 44, 128). I compared the growth of sse1∆
cells expressing SSE1, sse1nbd, or sse1sbd under cold stress or heat stress. While sse1sbd fully
complements sse1∆ cells grown in optimal conditions and under cold stress, the mutant allele could
not confer normal growth under heat stress (Figure 4-6). This behavior contrasted with the inability of
the sse1nbd allele to complement under any condition, suggesting that thermal stress may impose
distinct requirements for Sse1 functions that include NEF and substrate holdase activities. To further
probe this question, and to ask whether the presence of the closely related Sse2 protein masked
growth defects of sse1sbd under non-heat shock conditions, I transformed sse1∆sse2∆ cells with
sse1sbd- or SSE1-expressing plasmids using a plasmid shuffle technique (151). I again observed
indistinguishable growth between the two alleles at 30°C, while sse1sbd was unable to maintain
viability at 37˚C (Figure 4-6.A and B). Consistent with the phenotypes seen under thermal stress, cells
grown in the presence of formamide, which acts as a general protein denaturant, exhibited
phenotypes consistent with heat stress (Figure 4-6.C). Cells expressing the sse1nbd, or sse1sbd were
hypersensitive to formamide, and this phenotype was augmented with combined heat stress. These
results suggest that despite being unnecessary for substrate refolding and disaggregation in vitro, or
resistance to other forms of proteotoxic stress, the Sse1 SBD and its holdase activity are important for
cell physiology and survival under prolonged thermal stress.
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Figure 4-6. Sse1sbd supports growth at normal but not heat shock temperatures. A. Serial dilution
plating of sse1Δ or sse1Δsse2Δ cells complemented with the indicated plasmid-expressed SSE1 alleles
and cultured at the indicated temperatures. Wedges below images represent relative cell density. B.
Complementation of sse1Δsse2Δ with plasmid expressed Sse1 alleles at 30 °C. C. Serial dilution plating
of sse1Δ cells complemented with the indicated plasmid-expressed Sse1 alleles cultured on
formamide.
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I envisioned two possible explanations to account for the results obtained from the growth
analyses with sse1sbd. One is that Sse1 substrate binding is important only during heat stress due to
physiological insults that occur exclusively under those conditions. The second possibility is that the
Sse1 SBD is functioning at all times to maintain proteostasis. During normal growth conditions it
minimally contributes to the chaperones network, but it is takes on a more impactful role during heat
stress and is required to endure the increased burden on protein quality control systems. To
determine if a non-functional Sse1 SBD has any impact on the proteome while cells are grown under
optimal conditions, I assessed the activation of the heat shock response (HSR) as a proxy for
disruption of proteostasis using an established HSE-lacZ reporter (131, 132). To prevent possible
variability from plasmid expression in these and subsequent experiments, I chose to directly integrate
the SSE1 mutants into the yeast chromosome at the endogenous locus. It is known that sse1∆ cells
exhibit a two- to four-fold elevated HSR, consistent with chronic proteostatic imbalance (131). I
confirmed that cells expressing the NEF-defective allele sse1nbd also demonstrated an activated HSR
(Figure 4-7.A). Interestingly, cells expressing sse1sbd exhibited modest activation of the HSR (~1.8-fold)
supporting the idea that the Sse1 SBD may play some role in proteome maintenance even during nonstress conditions. As a complementary approach, I assessed Hsp90 expression since it is exclusively a
target of Hsf1 (156, 157) (10). Using immunoblot analysis, I determined that the sse1∆, sse1nbd, sse1sbd
cells exhibited a modest 1.5- to 3-fold increase in steady state Hsp90 levels in accordance with the
HSR activation results (Figure 4-7.B). These data suggest that the holdase activity of Sse1 nominally
contributes to proper functioning of the chaperone network under normal physiological conditions.
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Figure 4-7. Loss of Sse1 holdase activity results in mild proteotoxicity. A. β-galactosidase activity
assays from cells expressing the indicated SSE1 alleles integrated at the endogenous locus and
expressing the HSF reporter pSSA3HSE-lacZ grown under optimal conditions and in the absence of
stress (n=3). B. Protein lysates from cells grown to mid-log phase under optimal conditions and in the
absence of stress were analyzed for Hsp90 protein levels by SDS-PAGE and immunoblot. Scanning
densitometry quantitation of Hsp90 levels from blots and normalized to a PGK immunoblot as a load
control (n=3). Error bars represent ± standard deviation (p< 0.05).
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In addition to general contributions to proteostasis, Sse1 supports signal transduction and
functions of Hsp90 (114). For example, sse1∆ cells are especially sensitive to inhibitors that target
Hsp90-facilitated receptor activation such as geldanamycin and macbecin (131). To assess if this
biological role required Sse1 to functionally interact with unfolded substrates, I used the maturation
and activation of the mammalian glucocorticoid receptor (GR) in yeast cells as a benchmark of Hsp90
activity. β-galactosidase activity was measured in cells co-expressing a glucocorticoid response
element (GRE)-lacZ reporter and the different SSE1 alleles after activation of the GR via the synthetic
hormone deoxycorticosterone (DOC) (Figure 4-8). Wild-type cells exhibited a robust response to DOC
treatment indicative of GR activation. Likewise, cells expressing sse1sbd were also able to activate the
GR, whereas activation was abolished in sse1∆ and sse1nbd cells indicating that the Sse1 substrate
binding function is not required to contribute to this Hsp90-dependent activity. This is evidence that
the NEF function of Sse1 is primarily involved in Hsp90-mediated receptor activation.
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Figure 4-8. SBD function is not required for Hsp90-dependent glucocorticoid activation via Sse1.
Cells were grown under optimal conditions and activation of the rat glucocorticoid receptor was
measured via a LacZ reporter in the absence and presence of 10 µM deoxycorticosterone (DOC).
Luminescence was measured and the relative light units (RLU) detected were graphed as a mean
(n=4) with error bars representing ± standard deviation. *=p<0.05 and ns indicates no statistical
difference.
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Another established cellular role for Sse1 is its participation in the triage decision for Hsp70mediated protein folding versus degradation, wherein Sse1 is required for targeting terminally
misfolded proteins to the proteasome for degradation. Specifically, Sse1 stimulates ubiquitination and
degradation of the model misfolded protein CPYǂ-GFP, an engineered variant of the vacuolar protease
carboxypeptidase Y that lacks the ER signal sequence and is permanently misfolded (132, 133). I
utilized CPYǂ-GFP to assess if Sse1 substrate binding was important for targeting terminally misfolded
proteins for degradation. After treating cells with cycloheximide, I tracked the clearance of CPYǂ-GFP
in cells expressing SSE1, sse1ndb, or sse1sbd by immunoblot. In the presence of a fully functional Sse1
protein, CPYǂ-GFP levels decrease in cells after cycloheximide treatment as the misfolded protein is
degraded (Figure 4-9). I found that sse1nbd-expressing cells matched sse1∆ cells in their inability to
clear the terminally misfolded protein after two hours of cycloheximide chase. In contrast, sse1sbdexpressing cells fully cleared CPYǂ-GFP indicating that the Sse1 SBD function is not required for
targeting terminally misfolded proteins for degradation. In addition to immunoblot analysis, I
assessed the amount of CPYǂ-GFP aggregates forming in cells expressing the different Sse1 alleles and
tracked their clearance over time using fluorescence microscopy. CPYǂ-GFP aggregate clearance
correlated precisely with protein clearance (Figure 4-10.A and B). To test if Sse2 could be masking a
substrate binding role for Sse1 in protein degradation, I used SSE1sse2∆ and sse1sbdsse2∆ strains
(constructed by Unekwu Yakubu) and tracked the ability of these cells to clear the CPYǂ-GFP
aggregates. Cells expressing the substrate binding deficient mutant cleared the aggregates at the
same rate as SSE1sse2∆ cells (Figure 4-10.C and D). Although all the microscopy images were taken
with equal exposures, the images of cells at 90 minutes have very bright backgrounds due to the
overall decrease in cellular GFP signal. Together, these data strongly support the contention that Sse1
substrate binding is not required to support Hsp90 signaling activities or to promote the degradation
of terminally misfolded cytosolic proteins.
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Figure 4-9. Sse1 SBD function is not required for clearance of the misfolded CPYǂ-GFP reporter. A.
Immunoblot analysis of CPYǂ-GFP after a 2 hour cycloheximide treatment. Degradation of the CPYǂGFP was analyzed using anti-GFP antibody and PGK was used a load control. B. Scanning densitometry
quantitation was performed on anti-GFP blots and normalized to the PGK signal with in each sample.
The remaining normalized level of GFP signal was plotted after the 2 hour cycloheximide treatment
(n=3).

59

Figure 4-10. Sse1 SBD function is not required for clearance of the CPYǂ-GFP aggregates. A.
Representative micrographs of the various SSE1 strains at 0 and 90 min after cycloheximide treatment
to track CPYǂ-GFP aggregate clearance in the cell population. B. Quantitation of the experiments
shown in (A), percentage calculated as aggregate containing cells relative to time zero. Three
independent experiments were conducted and at least 95 cells were counted for each strain under
each time point. Error bars represent standard deviation and **=p<.01. C. Representative
micrographs of SSE1sse2∆ or sse1sbdsse2∆ strains tracking CPYǂ-GFP aggregate clearance at the
indicated time points. D. Quantitation of the experiments shown in (D), percentage calculated as
aggregate containing cells relative to time zero. Three independent experiments were conducted and
at least 136 cells were counted for each strain under each time point. Error bars represent standard
deviation, and ns indicates no statistical difference. All experiments were performed using cells
expressing the indicated SSE1 alleles integrated at the endogenous locus.
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Discussion

Among the three classes of cytosolic NEFs, Hsp110/Sse is the sole family demonstrated to
possess holdase activity for unfolded proteins, yet no in vivo role has been exclusively attributed to
this domain. To address this quandary, I generated a novel Sse1 allele that disrupts the ability of the
chaperone to prevent aggregation, presumably via substrate binding and sequestration, while
maintaining interaction with Hsp70 and NEF activity. Data from our laboratory and others strongly
suggest that the yeast cytosolic Hsp110s, Sse1 and Sse2, play critical cellular roles in maintaining
protein homeostasis during physiological and stress conditions (114, 131, 132). This interpretation is
bolstered by the fact that sse1∆sse2∆ cells are unviable and while overexpression of the other yeast
NEFs can only partially complement growth phenotypes at 30˚C, the complete absence of Hsp110
proteins can only be fully remedied by expression of either SSE1 or SSE2 (114). In all cases studied to
date, elimination of Hsp110/Sse NEF activity phenocopies the gene deletion, suggesting that indeed,
the NEF function is a primary, if not dominant, role for this class of chaperone. Known Sse1 roles that
might additionally be impacted by loss of Hsp110/Sse holdase activity were tested such as refolding
and disaggregation in vitro, responses to different proteotoxic stresses, signaling through Hsp90, and
targeting of terminally misfolded cytosolic proteins for degradation. Strikingly, there was no
demonstrable role for Sse1 SBD function in the reconstituted luciferase refolding or disaggregation
reactions, leading us to conclude that the holdase activity is dispensable for these activities. Likewise,
Hsp90-dependent signaling and protein degradation were fully supported by the Sse1sbd mutant. This
is in apparent contrast to a recent study by the Hendershot group that identified two secretory
pathway proteins, immunoglobulin γ1 heavy chain and NS-1 κ light chain, that are preferentially
bound by the ER homolog of Hsp110, Grp170, and when this interaction is eliminated processing of
these substrates is disrupted (158). Although these findings suggest a biological role for Grp170
substrate binding, these same regions within the substrates are both aggregation-promoting and
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recognized by the ER Hsp40 co-chaperones ERdj4 and ERdj5, precluding a clear interpretation.
Additionally, models have been proposed wherein Hsp110 chaperones are competent to promote the
folding of unfolded substrates when assisted by Hsp40 co-chaperones in an ATP-dependent folding
cycle, an activity that would presumably rely on the SBD (111). However, the ability of catalytically
inactive SSE1 mutant alleles to fully support known Sse1-dependent activities challenges the
biological relevance of the observation by Matoo et al. in which Hsp110 was able to fold denatured
substrates in the absence of Hsp70 (39, 128).
It is possible that the Hsp110/Sse SBD plays a (minor and perhaps redundant) role in protein
folding events that is magnified under certain stress conditions. For example, Sse1sbd was unable to
serve as the sole Hsp110 allele under extended growth at 37˚C or in the presence of formamide, the
latter a phenotype that I and others have demonstrated to be functionally analogous to thermal
stress (159, 160). It cannot be excluded, however, that these phenotypes are ultimately more tightly
linked with cell wall integrity than protein homeostasis, an idea reinforced by the clear suppression of
sse1 mutant phenotypes with 1M sorbitol, an osmotic stabilizing agent (161).
It may be relevant to consider that the Sse1sbd mutant is not completely defective in substrate
binding, retaining between 20-50% of its aggregation prevention potential in a substrate-specific
manner. It is possible that a complete abrogation of substrate interaction is necessary to reveal more
dramatic phenotypes in the different Sse1 functions tested. However, I attempted to generate a more
severe holdase-defective mutant through additional targeted amino acid substitutions based on the
work of Liu and colleagues, without success (109). Importantly, I observed nearly identical outcomes
in multiple in vitro and in vivo assays that are highly dependent on Sse1 and sensitive to perturbations
in its status. Tellingly, the recently described role for Hsp110/Sse as a critical component of the
eukaryotic disaggregase machine provided a prime opportunity to answer the open question of
whether substrate holding by this family of proteins contributed to the remarkable ability of the
Hsp110•Hsp70•Hsp40 complex to extract and refold aggregated proteins. Our findings support the
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growing contention that Hsp110 NEF activity, not holdase activity, is the key accelerator of
disaggregation in this context (54). However, as the Sse1sbd mutant is not completely without
substrate binding capacity, I cannot yet formally exclude a role for substrate binding by Hsp110
chaperones in disaggregation. The passive holdase activity of Hsp110/Sse has previously been shown
to promote the refolding of luciferase by yeast cytosol, likely by stabilizing the unfolded polypeptide
and preventing its aggregation. This activity may also be compared to subtle interactions under
certain conditions with the Sup35 prion in yeast that appear to be independent of Sse1 NEF function
(162, 163). In both these latter scenarios the Sse1 holdase function is likely operating independently
of Hsp70.
It may be of interest to further probe potential contributions of Hsp110/Sse1 holdase activity
in aggregate prevention for specific aggregation-prone substrates. For example, Hsp105 in human
cells is known to modulate cystic fibrosis transmembrane conductance regulator (CFTR) folding and
processing (164). Hsp110 suppresses the aggregation and associated toxicity of the mutant proteins
that lead to amyotrophic lateral sclerosis and Alzheimer’s disease respectively, when expressed in C.
elegans and mice (123, 127). Hsp110 has also been found to be an important modulator of neuronal
degeneration caused by the expression of toxic polyglutamine proteins that model Huntington’s
disease in the fly (125, 126). Strikingly, Hsp110 can also ameliorate toxicity caused by the G85R
variant of SOD1, a contributor to amyotrophic lateral sclerosis (ALS), significantly extending survival of
SOD1G85R-YFP transgenic mice when overexpressed in motor neurons (165, 166). The specific
mechanisms by which Hsp110 prevents aggregation and disease progression in these model systems
are unknown. Given the increasing significance of Hsp110 chaperones in modulation of proteotoxic
aggregation, it will be important to more precisely define the features that contribute to such
activities as a precursor to therapeutically manipulating the chaperone network to combat
progression of protein-misfolding disorders.
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Chapter 5: A carboxyl-terminus regulated fluorescence affinity tag affects Sse1 functions
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Introduction

In parallel to the substrate binding function of SSE1 study discussed in chapter 4, I attempted
to find additional mutants of Sse1 that were substrate-binding defective. This was of particular
importance as the Sse1sbd mutant was only partially defective in substrate interactions (retained 2050% of substrate binding). In particular, I hoped to identify mutants that completely abolished
substrate interactions. In collaboration with Julie Heffler, an undergraduate student in the Morano
laboratory, we attempted to use manganese and Taq polymerase-induced mutagenesis to isolate SBD
mutants (130). The error-prone PCR mutagenesis screen was conducted by modulating Taq activity
through MgCl2 levels and nucleotide concentrations thus inducing transcription errors during PCR
amplification of the Sse1 SBD β-domain. The mutant β-domain DNA fragments amplified were
transformed into yeast cells along with a linearized vector and the DNA for the NBD and α-domain of
Sse1. Transformants were screened for wild-type growth at 30 ᵒC and a slow growth phenotype at 37
ᵒC. Heffler identified ten SSE1 mutants that demonstrated the desired growth phenotypes and the
candidates were analyzed for expression and protein stability at the two temperatures.
Unfortunately, none of the candidates were stable at the elevated temperature indicating that the
growth defect observed at 37 ᵒC was due to the absence of the Sse1 protein under that condition.
Additionally, we characterized multiple SBD site-directed mutants that were based on Hsp70 and
Hsp110 literature (103, 109, 167, 168). I built SSE1 alleles with the following mutations: SSE1SBD4V467T, SSE1-SBD5S440L, SSE1-SBD6P426L, and SSE1-SBD9Y404I,W406LL433A,N434P,F439L,M441A. The mutagenesis
screen and the targeted mutants did not yield in any Sse1 proteins that displayed the phenotypes of a
non-functional SBD while retaining stability and expression in vivo as well as Hsp70 interaction.
Because these methods were unsuccessful in producing viable mutants, I utilized a previously
developed strategy to modify Sse1 via a tunable, destabilized domain which acts a dominant degron
in the absence of a small molecule ligand. A publication from the Goldberg laboratory used a
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regulated fluorescent affinity (RFA) tag to control degradation of essential proteins in the parasite
Plasmodium falciparum (169). The RFA tag provides an avenue to knock down protein levels due to
the inherent instability of the dihydrofolate reducatse (DHFR) degradation domain (DDD) it contains.
The synthetic folate analog trimethoprim (TMP) binds the same site that folate binds within DHFR, so
the compound can be used in vivo to stabilize the DDD and prevent its degradation (170, 171).
Therefore, the RFA tag is unstable and degradation prone in the absence of a bound ligand but can be
stabilized when a ligand such as TMP is available. The researchers observed that the RFA was not
degraded when fused to PfHsp110 even in the absence of TMP, indicating some level of protection by
the molecular chaperone in P. falciparum. Their data suggested that the RFA tag fused to the Cterminus of PfHsp110 was bound by the chaperone’s SBD to protect the unstable domain and prevent
its degradation (169).
Based on these findings, the RFA tag was used as a tool to study the substrate binding
capabilities of Sse1. I proposed that the misfolded DDD in the absence of TMP would be recognized by
the Sse1 acting as a physical occlusion in the SBD of the chaperone. The RFA tag could be manipulated
through the absence or presence of TMP as an occluded or liberated Sse1 SBD, respectively. In this
study, the SSE1-RFA strain was often characterized along with sse1sbd as I expected that the two
proteins were inhibited in the ability to interact with substrate and would therefore show similar
phenotypes. While the sensitivity to proteomic stressors was similar, the cells expressing SSE1-RFA
were distinctively defective in degradation and aggregate clearance of a misfolded cytosolic protein.
Furthermore, the observed degradation defects in the SSE1-RFA strain were not rescued in the
presence of TMP. The data presented here suggest that the defects of the SSE1-RFA strain
demonstrates might be due to the presence of a tag on the C-terminus of Sse1 and not because the
tag contains a DDD within. To address this, I compared the SSE1-RFA strain to a strain which
expressed an Sse1 protein with a C-terminus GFP fusion (SSE1-GFP). Cells expressing SSE1-GFP also
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demonstrated reduced thermal tolerance at 37 ᵒC. These data suggest that a blocked C-terminus
interferes with specific Sse1 activities, possibly its roles in degradation.

Results

Given the work recently published by Muralidharan et. al., Sse1-RFA was used to characterize
the substrate binding function of Sse1 (130, 169). The RFA tag was hypothesized to interfere with the
ability of the Sse1 SBD to recognize or bind an unfolded polypeptide (Figure 5-1). This tag could serve
as a regulated Sse1 protein which could have an occluded SBD in the absence of trimethoprim (TMP)
and a liberated SBD in the presence of TMP which stabilizes the DDD within the tag. The SSE1-RFA
genetic construct was built by Julie Heffler, and she characterized SSE1-RFA cells for growth, assessed
the stability of Sse1-RFA in the presence and absence of TMP, and assessed the ability of the protein
to interact with Ssa and Ssb in vivo (130).
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Figure 5-1. Model of Sse1 fused to a carboxyl-terminus regulated fluorescence affinity (RFA) tag.
The RFA tag contains a GFP domain followed by a DHFR degradation domain (DDD) with an HA-tag on
the C-terminus. The degradation domain is inherently unstable and misfolded but can be stabilized in
the presence of the ligand, trimethoprim (TMP). When RFA is fused to Sse1, the unstable DDD is
recognized by the SBD of the chaperone to prevent degradation.
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To verify the functionality of SSE1-RFA, I wanted to assess complementation of the sse1∆
strain growth phenotypes (130). Plasmid-borne SSE1 alleles were expressed in sse1∆ cells and growth
was compared under optimal conditions, during cold stress, and heat stress (Figure 5-2.A). SSE1-RFA
cells show phenotypes very similar to those observed for the sse1sbd cells. Under optimal conditions
(30 ᵒC) and cold stress (15 ᵒC), both alleles complement the sse1∆ slow growth phenotypes and grow
significantly better than the non-functional sse1nbd cells. These data demonstrate that the SSE1-RFA
allele is a functional copy of SSE1 under these conditions. When cells are grown under heat stress (37
ᵒC) SSE1-RFA cannot complement the slow growth phenotype of the sse1∆ cells. The phenotypes
observed for SSE1-RFA cells reproduce the phenotypes expected for a non-functional Sse1 substrate
binding domain mutant such as the Sse1sbd (Figure 4-5). Previous work by Julie Heffler demonstrated
that SSE1-RFA cells are rescued from heat sensitivity when grown under the presence of TMP (cite
Julie’s thesis). I grew cells at 37 ᵒC with TMP, and obtained comparable results (Figure 5-2.A). The
phenotypic rescuing by TMP suggested that the RFA tag was functioning as predicted (Figure5-1).
Finally, similar to the phenotype of sse1sbd cells, the SSE1-RFA allele cannot complement the lethality
of sse1∆ sse2∆ cells at 37 ᵒC (Figure 5-2.B). These data also indicate that the Sse1-RFA protein is
functional under most conditions except under heat stress. In addition to heat stress, sse1∆ cells
complemented with the different SSE1 alleles were also grown in the presence of formamide, a
general protein denaturing agent (Figure 5-3). The phenotypes observed for SSE1-RFA cells were
similar to those of the sse1sbd mutant. These data suggest that Sse1-RFA could be functioning in a
similar fashion to the substrate binding domain mutant Sse1sbd.
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Figure 5-2. Sse1-RFA phenocopies the sensitivity to heat stress of the Sse1 substrate binding
mutant. A. Serial dilution plating of sse1Δ cells complemented with the indicated plasmid-expressed
SSE1 alleles and cultured at the indicated temperatures and in the presence of TMP. Wedges below
images represent relative cell density. B. Complementation of sse1Δsse2Δ with plasmid expressed
SSE1 alleles.
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Figure 5-3. Similar to a substrate binding mutant, Sse1-RFA is sensitive to formamide. Serial dilution
plating of sse1Δ cells complemented with the indicated plasmid-expressed Sse1 alleles cultured on
formamide at the indicated temperatures.
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I assessed if cells expressing the SSE1-RFA cells would behave like sse1sbd cells in a series of
experiments that I performed characterizing the substrate binding mutant (Chapter 4). Evaluating
these functions would require proper regulation of the SSE1 variants, so SSE1-RFA was integrated into
the yeast genome via allelic exchange. To ensure that SSE1-RFA cells were growing like the parental
strain (WT) as well as the SSE1 integrant, I calculated doubling times of the different SSE1 strains
under optimal conditions as a measurement of growth rate. As expected, WT, SSE1, sse1sbd, and SSE1RFA strains had similar doubling times of approximately 126 minutes. The sse1∆ and sse1nbd strains
grew more slowly and had doubling times of 261 or 178 minutes respectively (Figure 5-4.A). It is
established that sse1∆ cells exhibit a two- to four-fold elevated HSR, consistent with a proteostatic
imbalance (131). First, I wanted to assess the state of heat shock response (HSR) regulation as a
marker for general proteotoxicity. sse1∆ cells and those expressing the NEF-defective allele sse1nbd
demonstrated an activated HSR (Figure 5-4.B). Interestingly, SSE1-RFA cells had a lower activation (not
significant) of the HSR (~1.2 fold) compared to sse1sbd cells (~1.8-fold). Hsp90 is exclusively a target of
Hsf1, the master transcription regulator of the heat HSR (10, 156, 157). In parallel with the HSR
activation experiments, I measured Hsp90 protein levels (Figure 5-4.C). Corresponding with the HSR
activation results, the immunoblot analysis determined that the sse1∆, sse1nbd, sse1sbd cells exhibited
a modest 1.5- to 3-fold increase in steady state Hsp90 levels. SSE1-RFA cells displayed Hsp90 levels
between those of WT and the sse1sbd cells, much like the results for the HSR activation experiment.
These data suggest that Sse1 holdase activity contributes minimally to proper functioning of the
chaperone network and proteostasis under normal physiological conditions and lack of this function
results in a slight proteomic imbalance. SSE1-RFA cells were better able to maintain proteostasis than
sse1sbd cells, and these somewhat dissimilar phenotypes suggest that the defects of the Sse1-RFA
mutant are different from that of Sse1sbd. Interestingly, cells that express sse1nbd cells demonstrate a
higher derepression of the HSR in both the HSR-LacZ experiments as well as the analysis of Hsp90
levels, but the strain does not have a growth defect as severe as the sse1∆ cells. This suggests that the
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presence of a NEF defective Sse1 protein in the cell functions as a dominant negative and has a
proteotoxic effect. This observation was noted but was not further addressed experimentally.
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Figure 5-4. Sse1-RFA cells grow like wild-type cells and demonstrate a negligible HSR activation. A.
Doubling time in minutes for the WT (BY4741), sse1∆, and the various SSE1 genomic integrants (n=4).
B. β-galactosidase activity assays from cells expressing the indicated SSE1 alleles integrated at the
endogenous locus and expressing the HSF reporter pSSA3HSE-lacZ (n=3). Data was normalized to WT
(parent strain). C. Protein lysates from cells grown to mid-log phase were analyzed for Hsp90 protein
levels by SDS-PAGE and immunoblot. Scanning densitometry quantitation of Hsp90 levels from blots
and normalized to a PGK immunoblot as a load control (n=3). Error bars represent ± standard
deviation. *=p<0.05, **=p<0.01, ***=p<0.005, and ns indicates not statistically different.
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As discussed in Chapter 4, Sse1 promotes signal transduction and functions of Hsp90 (114,
131). I used the activation of the mammalian glucocorticoid receptor (GR) in yeast cells as a
benchmark of Hsp90 activity, to evaluate if the Sse1-RFA mutant had deficiencies in this biological role
of Sse1. β-galactosidase activity was measured in cells co-expressing a glucocorticoid response
element (GRE)-lacZ reporter and the different SSE1 alleles after activation of the GR via treatment
with the synthetic hormone deoxycorticosterone (DOC) (Figure 5-5). WT, SSE1, sse1sbd, and SSE1-RFA
cells exhibited a robust response to DOC treatment indicative of GR activation, whereas activation
was abolished in sse1∆ and sse1nbd cells implying that the NEF activity of Sse1 primarily drives
maturation of the GR via Hsp90.
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Figure 5-5. Sse1-RFA is capable of activating the Hsp90-dependent glucocorticoid receptor via Sse1.
Cells were grown under optimal conditions and activation of the rat glucocorticoid receptor was
measured via a LacZ reporter in the absence and presence of 10 µM deoxycorticosterone (DOC).
Luminescence was measured and the relative light units (RLU) detected were graphed as a mean
(n=4) with error bars representing ± standard deviation. *=p<0.05.
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Lastly, SSE1-RFA cells were tested for ability to execute the Sse1 established role of targeting
terminally misfolded proteins for degradation. I assessed this role in vivo by using CPYǂ-GFP which is
an engineered, terminally misfolded protein from the vacuolar protease carboxypeptidase Y that lacks
the ER signal sequence (131, 132). Cells were treated with cycloheximide to pause translation, and
CPYǂ-GFP clearance was assessed via immunoblot (Figure 5-6.A). CPYǂ-GFP was stabilized in sse1∆
cells expressing the vector, sse1nbd, and SSE1-RFA, whereas cells expressing SSE1 or sse1sbd were able
to degrade the model substrate. Additionally, I tracked clearance of CPYǂ-GFP aggregates in cells
containing the variant SSE1 alleles as genomic integrations following cycloheximide treatment (Figure
5-6.B and C).

Microscopic visualization demonstrated that SSE1-RFA cells have phenotypes

resembling those of sse1∆ and sse1nbd cells as they were unable to clear the CPYǂ-GFP aggregates.
Additionally, the micrograph image of SSE1-RFA cells that are not expressing CPYǂ-GFP demonstrates
that Sse1-RFA is a soluble protein and remains appropriately distributed throughout the cytosol
(Figure 5-6.B). Data from these experiments indicate that Sse1-RFA, in contrast to Sse1sbd, is not able
to target this misfolded protein for degradation. The inability of Sse1-RFA to clear CPYǂ-GFP from cells
might be due to an inhibition of the substrate binding function through the occlusion of the substrate
binding domain. Given that the sse1sbd cells were not defective degrading CPYǂ-GFP or in clearing its
aggregates, there was also the possibility that the phenotypes observed for SSE1-RFA were not due to
defective substrate binding function but something else being affected by the presence of the RFA
tag.
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Figure 5-6. Sse1-RFA is non-functional in clearing the misfolded CPYǂ-GFP substrate. A. Degradation
of CPYǂ-GFP was analyzed in sse1∆ cells expressing the plasmid-borne SSE1 variants. Immunoblot
analysis of CPYǂ-GFP degradation was performed at 0, 1, or 2 hours after cycloheximide treatment
was using anti-GFP antibody and PGK was used a load control. B. Representative micrographs of the
various SSE1 strains at 0 and 90 min after cycloheximide treatment to track CPYǂ-GFP aggregate
clearance in the cell population. C. Quantitation of the experiments shown in (B), percentage
calculated as aggregate containing cells relative to time zero. Three independent experiments were
conducted and at least 95 cells were counted for each strain under each time point. Error bars
represent standard deviation and **=p<.01.
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To test these possibilities, I repeated the experiments using the CPYǂ-GFP reporter in the
presence or absence of TMP. Given that TMP can rescue the growth defect of the SSE1-RFA strain
under heat conditions (Figure 5-2) (130), I expected that TMP would improve CPYǂ-GFP degradation.
Surprisingly, TMP did not have an effect on Sse1-RFA function. Immunoblot analysis to assess the
degradation of the protein showed that CPYǂ-GFP was stabilized in SSE1-RFA cells whether or not TMP
was present (Figure 5-7.A). Additionally, tracking the clearance of CPYǂ-GFP via microscopy also
demonstrated a TMP independent accumulation of aggregates (Figure 5-7.B).
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Figure 5-7. TMP does not rescue the clearance defect of SSE1-RFA cells. A. Degradation of CPYǂ-GFP
was analyzed in sse1∆ cells expressing the plasmid-borne SSE1 variants in the presence or absence of
TMP. Analysis was performed at 0, 1, or 2 hours after cycloheximide treatment was using anti-GFP
antibody and anti-PGK as a load control. B. Cells were grown in the absence (solid lines) or presence
(dotted lines) of 500 µM TMP. At least 90 cells per sample were visualized and cells containing foci of
total were counted at 0, 1, or 2 hours after cycloheximide treatment. Percentage calculated as
aggregate containing cells relative to time zero.
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Given the data obtained from the HSR activation and the CPYǂ-GFP substrate clearance
experiments, it was important to consider that Sse1-RFA was not behaving like the substrate binding
domain mutant, Sse1sbd. Furthermore, the inability of TMP to rescue the CPYǂ-GFP clearance defect
suggested that something other than SBD occlusion might be occurring with the Sse1-RFA protein.
Therefore, I hypothesized that Sse1-RFA was showing phenotypic defects due to the placement of the
RFA tag which could be interfering with other Sse1 activities. Experiments similar to those previously
conducted using the PfHsp110 were used to characterize the Sse1-RFA (169). I used proteins with an
N-terminus FLAG-tag expressed in sse1∆ yeast cells to measure the availability, or exposure, of the
different domains of Sse1-RFA. The RFA tag is comprised of a GFP domain, the DDD, and an HA-tag at
the C-terminus (Figure 5-1). If the DDD was bound by the substrate binding domain of Sse1, the GFP
domain would be less available to bind antibodies in its native state during an immunoprecipitation
(IP) based on the previous characterization of an Hsp110-RFA fusion (169). To ensure that the
proteins, F-Sse1, F-Sse1-RFA, and F-RFA, were expressed and properly folded, I began by conducting
an immunoprecipitation using FLAG antibody resin (Figure 5-8.A). As expected, the FLAG-tag
effectively immunoprecipitated all of the proteins as it is located at the N-terminus and is likely not
affected by SBD function or the presence of a tag at the C-terminus. Concurrent with what was
previously published, the FLAG-IP results reproduced data demonstrating that Sse1-RFA can interact
with the yeast cytosolic Hsp70 proteins suggesting that the NEF activity of the protein is intact (130).
A second IP was performed using Sepharose beads conjugated with anti-GFP monoclonal antibody
(Figure 5-8.B). If the RFA tag is bound by the SBD of Sse1, the GFP domain of Sse1-RFA would be less
available compared to that of the RFA tag alone. The GFP domain appeared to be available in the
Sse1-RFA fusion as well as the RFA alone. While these data do not guarantee that the DDD is not
bound by the Sse1 SBD, it does provide evidence that the GFP domain in the Sse1-RFA fusion is
unobstructed in the native state.
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Figure 5-8. The Sse1-RFA domains are accessible in vivo. A. Immunoprecipitation experiments using
FLAG-tagged proteins were performed using anti-FLAG conjugated resin. Samples were analyzed via
Coommassie stain on an SDS-PAGE. B. anti-GFP IP was performed using Sepharose beads conjugated
with anti-GFP monoclonal antibody. Samples were analyzed via SDS-PAGE and Coommassie stain.
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The results of the IP experiments provided evidence that the phenotypes observed for SSE1RFA cells were likely due to the presence of a tag on the C-terminus of the protein and not to the tag
being recognized as unstable and bound by the Sse1 SBD. I used GFP as a large alternative tag fused to
the C-terminus of Sse1 to test this conclusion (molecular weight: RFA 46 kDa, GFP: 27 kDa). SSE1-GFP
cells grow like WT cells under optimal conditions but have a growth defect under heat stress (Figure
5-9. A). Sse1 protein levels of the different strains where assessed by immunoblot and growth was
compared for the different SSE1 variants (Figure 5-9.B). The observed thermal sensitivity of the SSE1GFP strain phenocopies that of the SSE1-RFA strain. This indicates that the presence of a fused tag on
the C-terminus of Sse1 renders it unable to function optimally during heat stress. The sensitivity to
elevated temperatures exhibited by the Sse1-RFA and Sse1-GFP mutants indicate that heat stress
tolerance might require Sse1 interactions that are conferred by the extreme C-terminus of the
chaperone.
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Figure 5-9. A GFP tag on the C-terminus of SSE1 results in growth phenotypes similar to the SSE1RFA strain. A. Serial dilution plating of cells expressing the various SSE1 alleles integrated in the yeast
genome, including SSE1-RFA and SSE1-GFP, and cultured at the indicated temperatures. Wedges
below images represent relative cell density. B. SSE1 strains were serially diluted and cultured under
different temperature conditions.

Protein lysates from cells were analyzed by immunoblots

performed in parallel to the growth on solid media to determine protein expression levels. The
numbers below the anti-Sse1 immunoblot indicate the Sse1 protein level relative to the WT for each
temperature. PGK was used a load control and to normalize quantification.
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Discussion

Initially, Sse1-RFA was proposed as an alternative method to study the substrate binding
domain functions of SSE1. In the initial phases of the study, SSE1-RFA cells phenocopied the sse1sbd
strain (Figure 5-2). It was stable in yeast and maintained interactions with the cytosolic Hsp70s at 30ᵒ
C and 37ᵒ C (130) (Figure 5-8.A and B) It was particularly striking that SSE1-RFA cells demonstrated a
comparable sensitivity to heat, complete tolerance for cold stress, and complementation of the nonviable sse1∆sse2∆. Furthermore, the heat sensitivity was rescued by the presence of TMP as was
previously demonstrated (130). In addition to the growth assessments under optimal and stress
conditions, the SSE1-RFA strain displayed phenotypes that were slightly more defective that the SSE1
strain but less impacted than the sse1sbd strain in the assessments for the HSR regulation and the
activation of the glucocorticoid receptor (Figure 5-4 and 5-5). Taking these data together with the
work that was published using the PfHsp110-RFA, I posited that Sse1-RFA was a protein that was
defective in binding substrate due to the occlusion of the chaperone SBD by the DDD within the RFA
tag. I tested the ability of Sse1-RFA to function as a holdase in vitro using the aggregation assay
discussed in chapter 3. Although the data were preliminary (protein purity was low and only one
protein preparation was tested), they suggest that Sse1-RFA can bind unfolded citrate synthase
similarly to Sse1 (data not shown).
Surprisingly, during testing each Sse1 variant in its ability to degrade CPYǂ-GFP, the SSE1-RFA
strain provided phenotypes that were very different from those observed in the sse1sbd strain. These
results could be for two different reasons. One reason could be that the Sse1-RFA had a higher degree
of inhibition in binding substrate than the Sse1sbd that has up to a 50% reduction in its ability to
interact with unfolded substrates compared to Sse1 (Figures 4-2 and 4-3). If the Sse1-RFA SBD is
occluded by the RFA tag, it could be a complete inactivation of substrate binding by the pool of Sse1RFA in the cell given each chaperone is fused to a tag. The high degree of substrate binding inhibition
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in Sse1-RFA could result in the complete loss in ability to degrade CPYǂ-GFP or clear aggregates (Figure
5-6). The data presented in Figure 5-7 suggest that this rationale is incorrect because the presence of
TMP, which stabilizes the DDD within the RFA tag, does not rescue the CPYǂ-GFP degradation or
aggregate clearance phenotype in SSE1-RFA cells. Moreover, the immunoprecipitation experiments
did not indicate that the RFA is bound or occluded by the chaperone (Figure 5-8). There is still more
characterizing that needs to be completed in order to determine the availability of each domain in the
native Sse1-RFA.
If Sse1-RFA does not have a higher degree of inhibition in binding substrate than the Sse1sbd,
the other possibility is that the presence of the tag on C-terminus is preventing certain Sse1 functions.
This second possibility is supported by the data presented (Figure 5-7 and Figure 5-9).

Cells

expressing Sse1 fused with a C-terminal GFP (strain SSE1-GFP) also demonstrate sensitivity to heat. To
make a definitive conclusion regarding the effect a C-terminus tag has on Sse1 function, Sse1-RFA and
Sse1-GFP need to further characterized and compared. Moreover, Sse1 is known to work
cooperatively with the ubiquitin proteasome system when triaging terminally misfolded proteins for
degradation (132, 133, 153). It is possible that the degradation defects seen for the SSE1-RFA strain
might be due to the presence of the C-terminal tag which somehow inhibits those functions.
Ultimately, characterization of Sse1-RFA and other C-terminus obstructions would further our
understanding of Sse1 involvement in roles like targeting misfolded proteins for degradation.
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Chapter 6: Characterization of the Drosophila melanogaster Hsp110 (Hsc70cb)
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Introduction

In the cellular environment, proteins frequently encounter stress conditions that can cause
misfolding and aggregation. Additionally, genetic mutations can occur within cells that produce
irregular proteins which also form aggregates. Cellular protein inclusions caused by misfolded
proteins lead to cytotoxicity and disease (5). To reduce the potential effects of protein damage, a
network of molecular chaperones is deployed to protect the proteome by helping proteins fold or
clearing them from the cell. In animals, the inability of chaperones to counteract excessive protein
misfolding can lead to amyloid fibrillar aggregates that deposit around brain neurons contributing to
the development or progression of neurodegeneration: Alzheimer’s disease, Huntington’s disease and
Parkinson’s disease are all fundamentally diseases of protein misfolding (116, 117). A complete
understanding of the mechanisms of protein quality control is required to allow treatment of these
devastating pathological states.
Drosophila melanogaster is an excellent multicellular organism in which to study the
molecular basis of protein misfolding disorders. While flies cannot precisely reproduce the symptoms
associated with human neurodegenerative disorders, consequences of expressing the human mutant
protein that is characteristic of the disease can be visualized as phenotypes in a tissue specific
manner, usually the fly eye (172). Using Drosophila in this type of model can help in two ways. The
model can be used to gain an understanding of the molecular mechanisms that drive the pathology,
and also to find strategies to repress phenotypes of the mutant, disease-prone protein. Hsc70cb, the
fly Hsp110, was uncovered through an RNAi screen to be one of the most potent suppressors of
polyglutamine Htt aggregation in Drosophila cells (125). Using established fly models of Huntington’s
disease with controlled Hsp110 levels, confirmed that this chaperone could affect the formation of
aggregates as well as the progression of neuronal degradation (125, 126). Furthermore, Hsp110
associates with polyglutamine proteins in vivo, and in vitro studies indicate that this interaction is
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conferred through the SDB β domain of the chaperone(124). These studies provide motivation for
understanding how Hsp110 chaperones might interact with disease-prone proteins that contain
polyglutamine tract expansions.
In this study, I sought to characterize the D. melanogaster Hsp110 protein, Hsc70cb, and
develop mutants that were defective in binding substrate. Hsc70cb demonstrated holdase function in
the established in vitro aggregation assay (Chapter 3) which can be used to characterize substrate
binding mutants. Characterization of the wild-type Hsc70cb and a mutant collection could be utilized
to study the role that Hsp110 proteins play in modulating the disease progression in animal models of
neurodegenerative disorders.

Results

Hsp110 chaperones are a highly conserved family of proteins that exists in eukaryotes (40,
152). There are two Hsp110 homologs in yeast, one in flies, and three in humans (Figure 6) (65, 173,
174). Since flies only possess one gene that produces an Hsp110 protein, Hsc70cb, it makes this a
good animal model in which to study Hsp110 function as effects from homologs can be minimized.
The knowledge gained from studying the Sse1 substrate binding function can be utilized to
characterize the Hsc70cb given their high degree of conservation. The two proteins share 57%
similarity and highly comparable substrate binding domains.
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Figure 6-1. Characterizing the substrate binding domain in yeast, fly and human biology. A. Hsp110
homologs across various species B. Hsc70cb SBD structure (gray) was modeled based on the Sse1
crystal structure (blue) using Protein Homology/Analogy Recognition Engine V 2.0 (PHYRE 2) with a
confidence of 99.2% (59, 175).
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To evaluate if the proteins shared functional homology with each other, Hsc70cb was
expressed from a plasmid in sse1∆ cells and growth was assessed under optimal conditions and under
heat stress. The Hsc70cb expressing strain shows the same slow growth phenotypes of the sse1∆ cells
at either temperature indicating that the fly protein cannot functionally complement deletion of the
yeast HSp110 (Figure 6-2.A). These results could be due to poor expression or stability of the Hsc70cb
protein or because the D. melanogaster protein was not contributing to the yeast chaperone network.
To answer this question, FLAG-tagged Sse1 or Hsc70cb proteins were expressed in sse1∆ cells and a
FLAG immunoprecipitation was used to assess the ability of each Hsp110 protein to interact with the
yeast cytosolic Hsp70 (Ssa/Ssb) proteins (Figure 6-2.B). Whereas Hsp70 co-immunoprecipitated with
66% of Sse1, Hsp70 only co-immunoprecipitated with 18% of Hsc70cb (Figure 6-2.C). The slow growth
phenotype observed for the sse1∆ cells complemented with Hsc70cb was likely due to the inability of
the fly protein to interact with the yeast Hsp70 proteins. These results indicate that the Hsc70cb
cannot functionally complement the deletion of the yeast Hsp110 proteins.
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Figure 6-2. Hsp70cb does not complement an sse1∆ or interact with the yeast Hsp70s. A. Serial
dilution plating of sse1Δ cells complemented with the SSE1 or Hsc70cb alleles expressed from a
p413TEF vector and cultured at the indicated temperatures. Wedges below images represent relative
cell density. B. Co-immunoprecipitation experiments using FLAG-tagged Hsp110 proteins were
performed to assess interactions with the yeast Ssa and Ssb proteins. Samples were analyzed via
Coommassie stain on an SDS-PAGE. C. Quantitative analysis of band densities in (B). Error bars
indicate ± standard deviation and *=p<0.05.

92

Hsc70cb was tested for its ability to function as a nucleotide exchange factor using
recombinant protein purified from E. coli (Figure 6-3.A) (Figure 6-4). Human Hsc70 (HSPA8) had a high
level of nucleotide exchange in the presence of Hsc70cb. In fact the fly Hsp110 protein was a more
robust NEF when compared with Sse1. After ensuring that the purified Hsc70cb was NEF-functional,
the holdase activity of Hsc70cb could be assessed. Due to their high degree of conservation, I
expected that Hsc70cb would possess substrate binding function similar to other Hsp110 chaperones,
including those of yeast and mammals (30, 106, 107, 111). I measured its ability to prevent the
aggregation of chemically denatured firefly luciferase (FFL) using an established assay system (134).
Hsc70cb prevented the aggregation of FFL to a level that was comparable to SSE1 establishing that
Hsc70cb maintains the holdase function that is characteristic of Hsp110 chaperones.
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Figure 6-3. Substrate holding function is conserved in Hsp70cb. A. Nucleotide exchange activity
assays using HSPA8 (Hsp70) pre-bound to α-32P-ATP in the absence of NEF, or in the presence of
Hsc70cb or Sse1 for 15 min. B. Substrate aggregation experiments conducted using chemically
denatured CS (200 nM) diluted into refolding buffer without chaperone, with Hsc70cb (400 nM), or
with Sse1 (400 nM).
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Figure 6-4. Recombinant protein purification of Hexa-histidine tagged Hsc70cb. A. SDS-PAGE of 3 µg
of recombinant His6-Hsc70cb purified from E. coli visualized by Coommassie stain.
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Discussion
Initially, I proposed screening Hsc70cb SBD mutants by expressing the fly proteins in sse1∆
yeast cells. Given that the substrate binding defective mutants cannot complement the heat
sensitivity phenotype in this strain, this could be a quick and useful read-out to screen mutants.
Hsc70cb cannot complement an Sse1 deletion and cannot interact with the yeast cytosolic Ssa/Ssb;
therefore it is not possible to conduct this screen or study how Hsc70cb substrate interaction might
contribute to a chaperone network in vivo using yeast cells their chaperone networks. The Hsc70cb
chaperone will have to be characterized mechanistically in vitro and functionally characterized in the
fruit fly. To study the substrate binding function of Hsc70cb, I propose several mutants that target the
SBD of the protein (Figure 6-4). Hsc70cbsbd is a mutant that is analogous to the Sse1sbd characterized in
Chapter 5. Hsc70cbsbd9 has two additional residue substitutions at positions V401 and W403 that
target the putative binding site located within SBD-β stand β1 and L1,2 (Figure 6-1.B) (109). While the
Sse1-RFA mutant still needs to further characterized to determine its substrate binding capacity
(Chapter 5), the fact that it demonstrated deficiencies in the clearance of misfolded protein make this
a suitable candidate to test in the polyglutamine Htt fly model. Once the defect is mechanistically
defined for the C-terminus tag, this information can be used to study Hsc70cb. The proposed mutants
with internal deletions are based on the known Sse1 crystal structures as well as literature that has
characterized Hsp110 substrate binding in vivo (107) (124) (60) (104) (109). The mutants proposed
here can be tested for holdase function using the aggregation assay I established (Chapter 3 and
Figure 6-3.B). Developing mutants of Hsc70cb which are defective in specific functions and comparing
those mutants to wild-type or NEF defective proteins will help further our understanding of the role
that Hsp110 is playing in modulating the progression of the Huntington model of disease.
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Figure 6-4. Proposed mutants to characterize the substrate binding function of Hsc70cb while
retaining the NEF function. These Hsc70cb mutants target the SBD-β domain of the protein with
either targeted residue substitutions (depicted as a black x) or internal deletions (depicted as a dotted
line).
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Recently, the Hsp70, Hsp40, and Hsp110 chaperone machine has been established as a
powerful metazoan disaggregase machine with the capacity to resolublilize proteins (54, 110, 111,
155). Hsp110 proteins possess distinct molecular activities which include driving the nucleotidedependent Hsp70 as well as its independent substrate binding domain. These characteristics make it a
worthy chaperone to study in regard to neurodegenerative disorders and their causative cytotoxic
proteins. In a screen conducted by Dr. Sheng Zhang, he discovered that Hsp110 alleviates the
degenerative effects of aggregate formation by mutant Htt in D. melanogaster (125). Despite being
implicated in this and other amyloid disease models, Hsp110 has not been characterized for its
physiological role or how it may be contributing to protein quality control. It remains unknown how
the two distinct functions of Hsp110 contribute to neuronal protection. The knowledge gained from
this project can be applied to test whether the NEF or SBD function of Hsp110 is important in
modifying the progression of polyglutamine Htt based degeneration in the fly.
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Chapter 7: Discussion
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Summary

In this thesis, I present an analysis of the functions conferred by the substrate binding domain
of Hsp110 chaperones. In chapter 3, a novel technique is described which is used to characterize the
molecular dynamics of large protein complexes such as protein aggregates. I illustrate how a
microplate reader can be used to obtain signals comparable to right angle light scattering, which
typically requires a fluorimeter with a stirrable, temperature-controlled cell holder. The method
presented uses less protein and reagents, with the advantage of being able to test multiple conditions
in parallel. This account is an alternative method that can detect formation of rhodanese and citrate
synthase aggregates as well as the differential prevention of aggregate formation by the molecular
chaperone Sse1 with the same sensitivity as traditional methods of light scattering. Chapter 4 builds
on this technological development to characterize the substrate chaperoning capacity of Sse1, the
yeast Hsp110, through biochemical analysis. Furthermore, the work presented defines, for the first
time, the contribution of Sse1 substrate binding to the maintenance of cellular proteostasis. The work
presented in chapter 5 characterized a fusion protein of Sse1 which contained a regulated
fluorescence affinity tag. I anticipated that this protein fusion would render the substrate binding
domain of Sse1 non-functional, however several lines of evidence presented in the chapter suggest
that the SBD may remain competent while the carboxyl-terminal fusion interferes with a role for Sse1
in targeting substrates for degradation. Further characterization will have to be completed to
determine if the fusion protein is in fact inhibited for SBD function or an alternative Sse1 role or
interaction. Finally, Chapter 6 established that the fruit fly Hsc70cb behaves like a canonical Hsp110
with regard to interaction with Hsp70 and its ability to induce nucleotide exchange from the
chaperone. Additionally the data presented demonstrated that Hsc70cb can function as a holdase to
chaperone unfolded polypeptides. This creates a platform upon which Hsp110 functions can be
probed in a model for polyglutamine-mediated neurodegeneration in flies.
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Hsp110 as a nucleotide exchange factor and a substrate chaperone

Among the eukaryotic NEFs, which include the mitochondrial GrpE, and the cytosolic HspBP1,
and BAG families, the Hsp110 classes distinctively possess a substrate binding domain and therefore
are unique in their ability to interact with unfolded polypeptides. The nucleotide exchange function of
Hsp110 proteins has been extensively characterized (44, 45, 105, 152). The potent NEF activity of
these proteins is widely accepted as the driving force behind many Hsp70-mediated functions.
Previous work has characterized the substrate binding function of Hsp110 chaperones. Prior to this
study, it was known that Sse1 as well as mammalian Hsp110 can bind unfolded polypeptides in vitro
and this function is carried out by the substrate binding domain (30). The specific interaction was
localized to the SBD β by deletion mutagenesis (60, 106, 107, 109). Prior to this study a mutant of any
Hsp110 protein that inhibited substrate interactions while retaining the NEF function had not been
identified therefore the substrate binding function was never characterized in vivo. C-terminal
truncations produce unstable proteins that cannot interact with Hsp70 to induce nucleotide exchange
because this interaction is partially mediated by the SBD α of Hsp110 (45, 60). Separating these two
Hsp110 roles was integral to understanding the role each function was playing. Furthermore, by
separating the NEF and SBD activities it was possible to study how each contributes to chaperone
complexes.
Based on work published by other labs, I created a mutant that targeted the putative peptide
binding site of Sse1 (60). The mutant contained four amino acid substitutions within the Sse1 SBD β.
For the first time a stable and NEF functional protein was available to characterize Sse1 holdase
function independent of its other roles. The SBD defective mutant, Sse1sbd, was tested for its ability to
complement the established slow growth phenotype of sse1∆ cells. Sse1sbd was not able to rescue the
growth sensitivity under specific proteomic stressors such as heat and formamide. Moreover, the
Sse1sbd protein was able to rescue nonviable sse1∆sse2∆ cells but was insufficient to rescue those cells
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at elevated temperatures likely due to the absence of Sse2, In cells that expressed SSE2, with an intact
NEF and SBD, some Hsp110 activity was providing additional support to the chaperone network. This
was striking evidence that substrate binding by Sse proteins is required under specific stresses.

Hsp110 contribution to Hsp70 functions

This study assessed the contributions of NEF and SBD activity of Hsp110 in Hsp70-mediated
chaperone functions. In the absence of Sse1 function the HSR is activated even if cells are grown
under optimal conditions likely because of general protein misfolding that is occurring (131, 132).
Interestingly, when cells where grown under optimal conditions, the NEF-defective Sse1 strain
demonstrated high activation of the HSR indicating that those cells were under proteomic stress due
to the non-functional SSE1 allele they were expressing. I tested the activation of the HSR in cells that
carried an Sse1 with proper NEF activity but deficient in substrate interactions (chapter 4). Cells
expressing the substrate binding deficient sse1sbd also demonstrated an activation of the HSR, but it
was not as robust. These results are evidence that the Sse1 SBD partially contributes to proteome
maintenance but not to the extent that NEF function contributes. Another recognized Sse1 role is its
requirement in complex with Hsp70 and Hsp90 to promote maturation of protein clients. During cell
wall stress, the cooperative Hsp110-Hsp70-Hsp90 complex is required for the maturation of the Slt2
kinase which signals through the cell integrity pathway and activates the transcription factors SBF and
Rlm1 (161). In the same way, maturation of the glucocorticoid receptor (GR) requires Hsp110-Hsp70Hsp90 complex (114). A mature GR can activate the transcription of genes with GR elements (GRE) in
the promoter. I used the GR with GRE-lacZ system to assess the extent to which the Sse1 NEF or SBD
activities supplemented this Hsp70-Hsp90 mediated role. I hypothesized that Sse1, through its
holdase function, along with Hsp70 would maintain substrate in a competent state for Hsp90
activities, but the data indicate that the Sse1 NEF activity played the predominant role in GR
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maturation. In conclusion, the Hsp70-mediated Sse1 roles we tested showed that the SBD functions
contributes minimally to the tasks of the chaperone complex. Although I observed striking
phenotypes in the growth of cells expressing the SBD defective mutant under proteomic stress, this
could be due to a slight decrease in efficiency across multiple Sse1 or Hsp70 complex roles. It could be
that the slight deficiency across multiple functions compounds to produce a prominent growth
inhibition when the proteome is challenged.
In collaboration with Nadinath Nillegoda and the Bukau laboratory in Heidelberg, Germany,
we tested how the Sse1 SBD might contribute to the disaggregating and refolding function of the
Hsp70-Hsp40-Hsp110 machine. These in vitro experiments demonstrated that the Sse1 SBD is not
required for this function. It seems that the nucleotide exchange capacity of Sse1 is sufficient to drive
the protein folding machine. Previously published data are contradictory regarding whether or not the
Hsp110 can dissaggregate proteins in vitro collaboratively with Hsp40 and in the absence of Hsp70.
Matoo et. al. have published reports that human Hsp110 (HSP105 and Apg2) can act with Hsp40 in
the absence of Hsp70 to effectively refold denatured proteins and solubilize aggregates (111). This
activity would surely require substrate binding by the Hsp110 chaperone. Contradicting this model,
other published studies indicate that Hsp110 cannot function to dissaggregate or refold proteins in
the absence of Hsp70 (110, 155). They propose that it is through the Hsp110 NEF function that the
Hsp70-Hsp40-Hsp110 complex tackles protein aggregates. If Hsp110 can function as a dissaggregase
independent of Hsp70, it is reasonable to predict that the SBD function would be required to interact
with aggregated substrates. Along these lines, I did not explore the role that Sse1 might be playing in
repairing damaged proteins that are unfolded or worse, have segregated into aggregates. Analysis of
dissaggregation and refolding conducted in vivo would address this question. There is still much to
learn about the function of Hsp110 dissaggregase activity and if the SBD function plays any role.
The extent to which the substrate binding function of Sse1 is contributing to de novo protein
folding remains unexplored in other Hsp70 roles. Yeast possesses two distinct cytosolic yeast Hsp70
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systems. Whereas the SSA proteins are primarily involved in the rescue of stress denatured proteins
and helping cells tolerate stress, Ssb1/Ssb2 (SSB) play a major role in folding nascent polypeptides and
are dedicated to assisting protein biogenesis due to their localization to the ribosome (176). Once SSB
has released the ribosomal complex and is still substrate-bound, it interacts with Sse1 to induce
nucleotide cycling and peptide folding (83, 84). sse1∆ cells demonstrate growth sensitivity in the
presence of translation inhibitors hygromycin and cycloheximide (176). Additionally, sse1∆ cells
display high degree of overall protein aggregation which is increased further upon the deletion of the
nascent-polypeptide associated complex (NAC) which is functionally connected to SSB-mediated
protein folding (177). The NEF Snl1, a Bag-1 protein that is tethered to the endoplasmic reticulum (ER)
membrane, interacts with SSB in complex with the ribosome potentially to promote the nucleotide
exchange in SSB (82). Fes1, another abundant cytosolic NEF does not interact with SSB and only forms
a complex with Ssa proteins, (82, 132). The distinct post-ribosomal interactions of Sse1 suggest a role
in which this NEF contributes to folding or delivery of SSB substrates. It remains to be explored
whether Sse1 binds unfolded nascent chains while also interacting with SSB to induce nucleotide
cycling during de novo folding. The study discussed in this thesis tested the role of Sse1, focusing on
the substrate interaction function, in assisting the maturation of glucocorticoid receptor via Hsp90.
Sse1 has been implicated in in the processing or maturation of other yeast clients. For example, Sse1
can aid in the translocation of the yeast mating pheromone ppαF, in maintaining the v-Src tyrosine
kinase properly folded, and maturation of the Slt2 kinase via an Hsp70-Hsp90 interaction (44, 142,
161). While the experiments testing the ability of sse1sbd or SSE1-RFA strains to activate the
glucocorticoid receptor did not demonstrate a striking defect, I cannot rule out that the SBD or Cterminus of Sse1 plays a role in maturation of other protein clients.
Evidence suggests that Sse1 plays a major role in modulating the ubiquination of Hsp70
substrates that are irreparable. Sse1 is required for proper ubiquitination of misfolded cytoplasmic
substrates such as truncated Gnd1 (tGnd1), the mutant vacuolar protease CPY (CPYǂ), unstable DHFR
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mutants, and the artificially ubiquitinated substrate UbV76-Ura3 (133, 153). Sse1 is known to associate
with the von Hippel-Lindau (VHL) tumor-suppressor protein, when expressed in yeast, to promote its
degradation in association with Hsp70 (178). Moreover, Sse1 modulates the activity of the E3
ubiquitin ligases, Ubr1 and San1, in vivo (133,153) . I assessed the role that Sse1 plays in targeting
misfolded proteins for proteolysis by testing the Sse1nbd, Sse1sbd, and the Sse1-RFA mutants in their
ability to degrade CPYǂ-GFP. The Sse1sbd mutant displayed proper clearance of the misfolded
substrate, whereas Sse1nbd and Sse1-RFA could not fulfill this Sse1 function. The results for the Sse1nbd
strain are expected as this mutant has limited interaction with Hsp70 and therefore cannot
participate in a chaperone complex. It was surprising that Sse1-RFA cells demonstrated a defect so
distinct from the Sse1sbd strain. One explanation could be that the RFA moiety that is fused to Sse1
might interfere with allowing a ubiquitin ligase to access the permanently damaged protein substrate.
It is important to note that Fes1 has also been implicated in promoting the degradation of the
unstable DHFR mutants, but it plays no role in targeting CPYǂ or UbV76-Ura3 for proteolysis (132, 153).
This is evidence that there are functional and substrate distinctions between an Hsp70-Fes1 and an
Hsp70-Sse1 complex although these remain undefined. As I have mentioned previously, the substrate
binding and interactions have been characterized using model substrates, but it remains unknown
which native proteins are Sse1/Hsp110 substrates in vivo. The studies cited here and those that will
follow are important in defining the subset of proteins within the proteome of eukaryotes that are
Hsp110 dependent. Understanding this will further our ability to comprehend the mechanisms by
which chaperone networks prevent human disease.

The metazoan dissagregase

After stress, cells need to solubilize and reactivate aggregated proteins. Functional proteins
need to be refolded into their native state while terminally damaged proteins need to be cleared from
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the cell. Prokaryotes and non-metazoan eukaryotes have a well characterized dissaggregation system
which involves a powerful Hsp100 AAA+ ATPase, represented by Hsp104 in yeast (1, 13, 179). Hsp104
recovers proteins from aggregates as it threads polypeptides through the ring formed by the hexamer
and delivers these to Hsp70 (26). In concert with Hsp70 and Hsp40, Hsp104 acts a machine that can
break polypeptide loose from protein aggregates (1, 180).
Metazoans lack an Hsp100 protein that functions as a dedicated dissaggregase which raised
doubts about the ability of metazoan cells to clear aggregates. Recent work has established that a
metazoan dissaggregase composed of Hsp70-Hsp40-Hsp110 can disassemble aggregates and refold
proteins (54, 110, 111, 155). Hsp40 targets Hsp70 to damaged substrates and Hsp110 functions as the
preferred NEF to trigger aggregate dissolution (53, 110). Hsp110 is represented in mammals as three
homologs, Hsp105α, Apg-1, and Apg-2 and is one of three classes of cytosolic NEFs which include the
HspBP1-type and the Bag-type. In parallel to the studies cited, which characterized the dissagregase
machine in vitro, Hsp105α knockout mouse cells were impaired in reactivating aggregated heatdenatured luciferase (181). Likewise, a study in C. elegans also showed defects in aggregate clearance
when Hsp110 was depleted (110). These data indicate that Hsp110 proteins have a distinctive
function that other NEFs in metazoans cannot accomplish.
Taking into account that the Hsp100 proteins in bacteria and fungi act in concert with Hsp70
and Hsp40 to create a machine which can “pull” aggregates apart to produce free polypeptides, it is
possible that the substrate binding function of Hsp110 chaperones is required to propel this machine.
The study presented in chapter 6 forms the basis for this next line of investigation. Using the D.
melanogaster Hsp110 (Hsc70cb) chaperone mutant collection I proposed, a member of my
laboratory, Unekwu Yakubu, is currently addressing this question. Finding mutants of Hsp110 that can
isolate the NEF and the SBD functions is imperative to understand the molecular mechanism by which
this chaperone modulates aggregates. These mutants can be tested in vitro using the aggregation
assay described in chapter 3 with a polyglutamine protein substrate or by developing a
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dissaggregation and refolding assay. Beyond the biochemical characterization, the Hsc70cb mutants
can be used to investigate the role of Hsp110 substrate interactions in the previously characterized
fruit fly model polyglutamine-based neurodegeneration (125).

Implications of Hsp110 in molecular progression of neurodegeneration

Cellular proteostasis collapses when cells experience chronic proteotoxic stress and can lead
to an accumulation of misfolded proteins. With the progression of age, cells also accumulate
mutations that can produce toxic protein species (21, 28). Protein misfolding and aggregation have
serious consequences for human disease ranging from many neurodegenerative diseases to diabetes
(182). Neurodegeneration in disorders like Alzheimer’s (AD), Parkinson’s (PD), Huntington’s (HD)
disease, and Amyotrophic Lateral Sclerosis (ALS) are characterized by protein aggregates or plaques
that form in and around neurons (120). In vitro and in vivo studies have demonstrated that molecular
chaperones, particularly Hsp110, can modulate protein aggregation and can lessen the effect of the
toxic protein species that cause cellular degeneration (28). Hsp110 proteins have been effective in
preventing toxicity caused by hyperphosphorylated tau, polyglutamine proteins, and mutant SOD1 in
mice, flies , and nematodes respectively (123-127). Hsp110 association with polyglutamine proteins
and SOD1 mutants has been demonstrated in animal models (124) (127). The proteins that cause
neurodegenerative disorders are not necessarily similar other than their common β-sheet rich regions
that lead to aggregation and form stable amyloid fibrils (120). As mentioned in the previous section,
humans do not possess the traditional Hsp100 dissaggregase, but there is evidence that the Hsp70Hsp40-Hsp110 complex can fulfill this role in metazoans.
These discoveries are recent and much is still unknown about the molecular mechanism that
Hsp110 alone or in concert with Hsp70 is playing to modulate the effects of these toxic proteins. For
example, Hsp110 is able to delay the onset of neurodegeneration by preventing the formation of
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plaques, but it remains unclear how this occurs. Does Hsp110 help to fold amyloid-prone proteins to
prevent the formation of amyloid plaques? Does Hsp110 act to hold amyloidogenic proteins in a
soluble state until other chaperones can perform protein triage? Does Hsp110 promote the
degradation of the amyloidogenic proteins directly? If the molecular mechanisms by which this is
achieve can be understood, that specific chaperoning activity can be targeted to slow disease
progression. Currently no treatments exist which can cure or reverse the impacts of
neurodegenerative diseases. An incomplete understanding of molecular chaperones and the
mechanisms by which specific substrate damage can be cleared or prevented to reverse proteome
damage has resulted in limited therapeutic options.

Hsp110 holdase as a clinical tool

Finally, HSPs are currently being investigated for their benefits as vaccine adjuvants and are
used to deliver antibodies, peptides, and antigens (183). Recent reports have indicated that Hsp110 is
an excellent candidate to use when trying to deliver vaccine immunogens. It is particularly the ability
of Hsp110 to bind substrate tightly and to chaperone vulnerable proteins that made it useful. Hsp110
can form a chaperone complex with large protein substrates, so researches are exploiting this
chaperone function to deliver highly immunogenic cancer vaccines which can suppress tumors (184).
For example, the intracellular domain (ICD) of HER-2/neu, an antigen relevant to breast cancer, was
used in a complex with Hsp110 to elicit a specific immune response to the ICD without having
secondary effects due to the presence of chaperone (185). These therapeutic application of the
HSp110 substrate binding capability have been successful and are currently being utilized in clinical
trials (186). In conclusion, Sse1/Hsp110 are worthy candidates to explore eukaryotic proteome
maintenance for their capacity of modulate disease as well as their potential use to chaperone
substrates that need to be delivered as therapies.
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